Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	extracellular matrix constituent, lubricant activity	MUC17 MUC3A MUC4	5.63e-07	4	105	3	GO:0030197
GeneOntologyMolecularFunction	modification-dependent protein binding	ANK3 TOPBP1 TAB2 PHF2 SETD5 SMARCA4 KMT2A PHIP RAD23B	1.42e-06	206	105	9	GO:0140030
GeneOntologyMolecularFunction	tubulin binding	TPR MAP1A CLASP1 CLIP2 MAP4 PEX14 CCDC88C DST ALMS1 FAM83D APPL1	1.58e-05	428	105	11	GO:0015631
GeneOntologyMolecularFunction	protein-macromolecule adaptor activity	TPR DLG5 ANK3 MAP1A SERTAD2 DVL3 TOPBP1 PEX14 RAD54L2 SRCAP WNK1 PHF2 TSC22D1 MAVS SETD5 CBFA2T2 SMARCA4 MUC1	3.24e-05	1160	105	18	GO:0030674
GeneOntologyMolecularFunction	microtubule binding	MAP1A CLASP1 CLIP2 MAP4 PEX14 CCDC88C DST ALMS1 FAM83D	3.62e-05	308	105	9	GO:0008017
GeneOntologyMolecularFunction	molecular adaptor activity	TPR DLG5 ANK3 MAP1A SERTAD2 DVL3 TOPBP1 PEX14 TAB2 RAD54L2 SRCAP WNK1 PHF2 TSC22D1 MAVS SETD5 CBFA2T2 SMARCA4 MUC1	7.58e-05	1356	105	19	GO:0060090
GeneOntologyMolecularFunction	cytoskeletal protein binding	TPR DLG5 XIRP1 ANK3 MAP1A CLASP1 CLIP2 MAP4 PEX14 MAP3K1 CCDC88C DST ALMS1 PLEKHG3 FAM83D APPL1	1.95e-04	1099	105	16	GO:0008092
GeneOntologyMolecularFunction	microtubule plus-end binding	CLASP1 CLIP2 DST	2.02e-04	22	105	3	GO:0051010
GeneOntologyMolecularFunction	histone binding	SRCAP PHF2 SETD5 MCM3AP SMARCA4 KMT2A PHIP	5.04e-04	265	105	7	GO:0042393
GeneOntologyMolecularFunction	lysine-acetylated histone binding	SMARCA4 KMT2A PHIP	5.17e-04	30	105	3	GO:0070577
GeneOntologyMolecularFunction	acetylation-dependent protein binding	SMARCA4 KMT2A PHIP	5.71e-04	31	105	3	GO:0140033
GeneOntologyMolecularFunction	transcription coregulator activity	SERTAD2 PEX14 RAD54L2 SRCAP PHF2 TSC22D1 SETD5 CBFA2T2 SMARCA4 MUC1	7.57e-04	562	105	10	GO:0003712
GeneOntologyMolecularFunction	structural molecule activity	TPR KRT5 KRT13 ANK3 MAP1A MAP4 H1-8 DST MUC17 MUC3A MUC4 MUC5AC MUC6	7.98e-04	891	105	13	GO:0005198
GeneOntologyMolecularFunction	ATP-dependent chromatin remodeler activity	RAD54L2 SRCAP SMARCA4	9.64e-04	37	105	3	GO:0140658
GeneOntologyMolecularFunction	phosphorylation-dependent protein binding	ANK3 TOPBP1	1.20e-03	10	105	2	GO:0140031
GeneOntologyMolecularFunction	guanyl-nucleotide exchange factor activity	DOCK1 RALGDS RASGRF2 ARHGEF38 CCDC88C PLEKHG3	1.39e-03	231	105	6	GO:0005085
GeneOntologyMolecularFunction	frizzled binding	DVL1 DVL3 CCDC88C	1.40e-03	42	105	3	GO:0005109
GeneOntologyBiologicalProcess	positive regulation of transcription by RNA polymerase II	KLF12 RBM15 VEZF1 DVL1 DVL3 SRF RAD54L2 MAP3K1 EBF2 KANSL3 TSC22D1 USF3 MAVS HOXD13 ASXL3 SMARCA4 KMT2A ELF1 NR3C2 MUC1 PHIP MIR9-1HG	1.56e-06	1390	105	22	GO:0045944
GeneOntologyBiologicalProcess	regulation of chromatin organization	TPR PPHLN1 PHF2 SETD5 KMT2A	1.77e-06	40	105	5	GO:1902275
GeneOntologyBiologicalProcess	regulation of heterochromatin formation	TPR PPHLN1 PHF2 KMT2A	6.23e-06	24	105	4	GO:0031445
GeneOntologyBiologicalProcess	morphogenesis of a polarized epithelium	DLG5 DVL1 DVL3 ALMS1 SEC24B	3.54e-05	73	105	5	GO:0001738
GeneOntologyBiologicalProcess	regulation of establishment of planar polarity involved in neural tube closure	DVL1 DVL3 SEC24B	5.58e-05	15	105	3	GO:0090178
GeneOntologyBiologicalProcess	establishment of planar polarity involved in neural tube closure	DVL1 DVL3 SEC24B	6.84e-05	16	105	3	GO:0090177
GeneOntologyBiologicalProcess	establishment of planar polarity	DVL1 DVL3 ALMS1 SEC24B	7.36e-05	44	105	4	GO:0001736
GeneOntologyBiologicalProcess	morphogenesis of an epithelium	DLG5 RBM15 CLASP1 DVL1 DVL3 SRF MAP3K1 ALMS1 HOXD13 SEC24B SMARCA4 HECTD1	7.36e-05	619	105	12	GO:0002009
GeneOntologyBiologicalProcess	microtubule cytoskeleton organization	TPR ANK3 MAP1A CLASP1 CLIP2 MAP4 DVL1 PEX14 CCDC57 CCDC88C DST ALMS1 POC1B	7.46e-05	720	105	13	GO:0000226
GeneOntologyBiologicalProcess	establishment of tissue polarity	DVL1 DVL3 ALMS1 SEC24B	8.05e-05	45	105	4	GO:0007164
GeneOntologyBiologicalProcess	establishment of planar polarity of embryonic epithelium	DVL1 DVL3 SEC24B	9.89e-05	18	105	3	GO:0042249
GeneOntologyBiologicalProcess	regulation of establishment of planar polarity	DVL1 DVL3 SEC24B	1.17e-04	19	105	3	GO:0090175
GeneOntologyBiologicalProcess	epithelium development	KRT5 DLG5 RBM15 CDSN KRT13 VEZF1 CLASP1 DVL1 DVL3 SRF PPHLN1 MAP3K1 CCDC88C ALMS1 HOXD13 CBFA2T2 SEC24B SMARCA4 HECTD1	1.42e-04	1469	105	19	GO:0060429
GeneOntologyBiologicalProcess	membraneless organelle assembly	TPR XIRP1 CLASP1 SRF WNK1 CCDC57 MDN1 ALMS1 ATXN2 POC1B	1.56e-04	475	105	10	GO:0140694
GeneOntologyBiologicalProcess	facultative heterochromatin formation	PPHLN1 PHF2 SMARCA4 KMT2A	1.77e-04	55	105	4	GO:0140718
GeneOntologyBiologicalProcess	chromatin organization	TPR RBM15 TOPBP1 PPHLN1 RAD54L2 SRCAP EZHIP KANSL3 PHF2 H1-8 SETD5 MCM3AP SMARCA4 KMT2A	1.79e-04	896	105	14	GO:0006325
GeneOntologyBiologicalProcess	heterochromatin formation	TPR RBM15 PPHLN1 PHF2 SMARCA4 KMT2A	1.88e-04	163	105	6	GO:0031507
GeneOntologyBiologicalProcess	epigenetic regulation of gene expression	TPR RBM15 PPHLN1 EZHIP PHF2 H1-8 SMARCA4 KMT2A	2.86e-04	330	105	8	GO:0040029
GeneOntologyBiologicalProcess	cell morphogenesis	ANK3 MAP1A DVL1 DVL3 SRF FRYL MAP3K1 CCDC88C DST ATXN2 SEC24B POC1B SMARCA4 UNK MUC3A PHIP	3.44e-04	1194	105	16	GO:0000902
GeneOntologyBiologicalProcess	establishment or maintenance of cell polarity	DLG5 ANK3 CLASP1 SPN MAP4 DST PLEKHG3	3.46e-04	257	105	7	GO:0007163
GeneOntologyBiologicalProcess	supramolecular fiber organization	KRT5 CDSN XIRP1 KRT13 MAP1A CLASP1 CLIP2 MAP4 DVL1 SRF CCDC57 MAP3K1 CCDC88C ALMS1	3.50e-04	957	105	14	GO:0097435
GeneOntologyBiologicalProcess	cytoplasmic microtubule organization	CLASP1 CLIP2 DVL1 CCDC88C	3.59e-04	66	105	4	GO:0031122
GeneOntologyBiologicalProcess	negative regulation of heterochromatin formation	PHF2 KMT2A	3.80e-04	6	105	2	GO:0031452
GeneOntologyBiologicalProcess	chromatin remodeling	TPR RBM15 PPHLN1 RAD54L2 SRCAP EZHIP PHF2 H1-8 SETD5 MCM3AP SMARCA4 KMT2A	3.88e-04	741	105	12	GO:0006338
GeneOntologyBiologicalProcess	tissue morphogenesis	DLG5 RBM15 CLASP1 DVL1 DVL3 SRF MAP3K1 ALMS1 HOXD13 SEC24B SMARCA4 HECTD1	4.32e-04	750	105	12	GO:0048729
GeneOntologyBiologicalProcess	negative regulation of chromatin organization	PHF2 KMT2A	5.30e-04	7	105	2	GO:1905268
GeneOntologyBiologicalProcess	protein-DNA complex organization	TPR RBM15 TOPBP1 PPHLN1 RAD54L2 SRCAP EZHIP KANSL3 PHF2 H1-8 SETD5 MCM3AP SMARCA4 KMT2A	5.38e-04	999	105	14	GO:0071824
GeneOntologyBiologicalProcess	morphogenesis of an epithelial sheet	CLASP1 DVL1 SRF MAP3K1	5.55e-04	74	105	4	GO:0002011
GeneOntologyCellularComponent	Golgi lumen	MUC21 MUC3B MUC19 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	3.56e-13	109	107	12	GO:0005796
GeneOntologyCellularComponent	spindle	TPR CLASP1 MAP4 TOPBP1 WNK1 CCDC57 CEP170 ALMS1 POC1B FAM83D	1.53e-04	471	107	10	GO:0005819
GeneOntologyCellularComponent	dendritic microtubule	MAP1A CLIP2	1.55e-04	4	107	2	GO:1901588
GeneOntologyCellularComponent	microtubule plus-end	CLASP1 CLIP2 DST	3.89e-04	28	107	3	GO:0035371
Domain	SEA	MUC3B MUC16 MUC12 MUC17 MUC1 MUC3A	2.27e-09	23	103	6	PS50024
Domain	SEA_dom	MUC3B MUC16 MUC12 MUC17 MUC1 MUC3A	2.27e-09	23	103	6	IPR000082
Domain	SEA	MUC3B MUC16 MUC17 MUC1 MUC3A	8.90e-09	14	103	5	SM00200
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC MUC6	1.93e-08	16	103	5	SM00216
Domain	VWF_type-D	MUC19 MUC5B MUC4 MUC5AC MUC6	1.93e-08	16	103	5	IPR001846
Domain	VWFD	MUC19 MUC5B MUC4 MUC5AC MUC6	1.93e-08	16	103	5	PS51233
Domain	VWD	MUC19 MUC5B MUC4 MUC5AC MUC6	1.93e-08	16	103	5	PF00094
Domain	SEA	MUC3B MUC16 MUC12 MUC17 MUC1	1.13e-07	22	103	5	PF01390
Domain	TIL	MUC19 MUC5B MUC5AC MUC6	4.17e-07	12	103	4	PF01826
Domain	C8	MUC19 MUC5B MUC5AC MUC6	4.17e-07	12	103	4	PF08742
Domain	Unchr_dom_Cys-rich	MUC19 MUC5B MUC5AC MUC6	6.00e-07	13	103	4	IPR014853
Domain	C8	MUC19 MUC5B MUC5AC MUC6	6.00e-07	13	103	4	SM00832
Domain	TIL_dom	MUC19 MUC5B MUC5AC MUC6	8.37e-07	14	103	4	IPR002919
Domain	VWC_out	MUC19 MUC5B MUC5AC MUC6	3.17e-06	19	103	4	SM00215
Domain	CT	MUC19 MUC5B MUC5AC MUC6	5.91e-06	22	103	4	SM00041
Domain	Cys_knot_C	MUC19 MUC5B MUC5AC MUC6	1.01e-05	25	103	4	IPR006207
Domain	CTCK_2	MUC19 MUC5B MUC5AC MUC6	1.01e-05	25	103	4	PS01225
Domain	Mucin_dom	MUC21 MUC22	3.01e-05	2	103	2	IPR028199
Domain	Epiglycanin_C	MUC21 MUC22	3.01e-05	2	103	2	PF14654
Domain	-	MUC16 MUC17 MUC1	7.06e-05	15	103	3	3.30.70.960
Domain	VWF_dom	MUC19 MUC5B MUC5AC MUC6	8.31e-05	42	103	4	IPR001007
Domain	Dsh_C	DVL1 DVL3	9.00e-05	3	103	2	PF12316
Domain	Dishevelled_C-dom	DVL1 DVL3	9.00e-05	3	103	2	IPR024580
Domain	CTCK_1	MUC19 MUC5B MUC5AC	1.25e-04	18	103	3	PS01185
Domain	Dsh/Dvl-rel	DVL1 DVL3	1.79e-04	4	103	2	IPR015506
Domain	HSA	SRCAP SMARCA4	1.79e-04	4	103	2	SM00573
Domain	Dishevelled_fam	DVL1 DVL3	1.79e-04	4	103	2	IPR008339
Domain	Dishevelled	DVL1 DVL3	1.79e-04	4	103	2	PF02377
Domain	HSA	SRCAP SMARCA4	1.79e-04	4	103	2	PS51204
Domain	Dishevelled_protein_dom	DVL1 DVL3	1.79e-04	4	103	2	IPR003351
Domain	HSA_dom	SRCAP SMARCA4	1.79e-04	4	103	2	IPR014012
Domain	HSA	SRCAP SMARCA4	1.79e-04	4	103	2	PF07529
Domain	WxxW_domain	MUC5B MUC5AC	4.45e-04	6	103	2	IPR025155
Domain	Mucin2_WxxW	MUC5B MUC5AC	4.45e-04	6	103	2	PF13330
Domain	-	ARHGEF38 APPL1 ACAP3	5.93e-04	30	103	3	1.20.1270.60
Domain	AH/BAR-dom	ARHGEF38 APPL1 ACAP3	5.93e-04	30	103	3	IPR027267
Domain	DIX	DVL1 DVL3	6.21e-04	7	103	2	PF00778
Domain	DIX	DVL1 DVL3	6.21e-04	7	103	2	IPR001158
Domain	DIX	DVL1 DVL3	6.21e-04	7	103	2	PS50841
Domain	DAX	DVL1 DVL3	6.21e-04	7	103	2	SM00021
Domain	SNF2_N	RAD54L2 SRCAP SMARCA4	7.19e-04	32	103	3	IPR000330
Domain	SNF2_N	RAD54L2 SRCAP SMARCA4	7.19e-04	32	103	3	PF00176
Domain	VWC	MUC19 MUC5B MUC5AC	1.19e-03	38	103	3	SM00214
Domain	VWFC_2	MUC19 MUC5B MUC5AC	1.19e-03	38	103	3	PS50184
Domain	BROMODOMAIN_2	SMARCA4 KMT2A PHIP	1.49e-03	41	103	3	PS50014
Domain	BROMO	SMARCA4 KMT2A PHIP	1.60e-03	42	103	3	SM00297
Domain	Bromodomain	SMARCA4 KMT2A PHIP	1.60e-03	42	103	3	IPR001487
Domain	-	SMARCA4 KMT2A PHIP	1.60e-03	42	103	3	1.20.920.10
Domain	Ras_G-nucl-exch_fac_CS	RALGDS RASGRF2	2.62e-03	14	103	2	IPR019804
Domain	Glyco_hormone_CN	MUC5B MUC5AC	3.02e-03	15	103	2	IPR006208
Domain	Cys_knot	MUC5B MUC5AC	3.02e-03	15	103	2	PF00007
Domain	DH_1	RASGRF2 ARHGEF38 PLEKHG3	5.09e-03	63	103	3	PS00741
Domain	RasGEFN	RALGDS RASGRF2	5.36e-03	20	103	2	SM00229
Pathway	REACTOME_DEFECTIVE_GALNT3_CAUSES_HFTC	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	2.52e-19	16	84	10	M27410
Pathway	REACTOME_DEFECTIVE_C1GALT1C1_CAUSES_TNPS	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	6.10e-19	17	84	10	M27412
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	3.49e-17	23	84	10	M556
Pathway	REACTOME_DECTIN_2_FAMILY	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	1.60e-16	26	84	10	M27483
Pathway	REACTOME_TERMINATION_OF_O_GLYCAN_BIOSYNTHESIS	MUC21 MUC19 MUC16 MUC5B MUC17 MUC1 MUC4 MUC5AC MUC6	1.69e-15	21	84	9	MM15706
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	2.72e-12	62	84	10	M546
Pathway	REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	7.14e-12	68	84	10	M27303
Pathway	REACTOME_O_LINKED_GLYCOSYLATION_OF_MUCINS	MUC21 MUC19 MUC16 MUC5B MUC17 MUC1 MUC4 MUC5AC MUC6	7.05e-11	60	84	9	MM15636
Pathway	REACTOME_C_TYPE_LECTIN_RECEPTORS_CLRS	MUC21 MUC16 TAB2 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	6.24e-10	140	84	11	M27484
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	1.03e-09	111	84	10	M27416
Pathway	REACTOME_DISEASES_OF_GLYCOSYLATION	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	1.22e-08	143	84	10	M27275
Pathway	REACTOME_O_LINKED_GLYCOSYLATION	MUC21 MUC19 MUC16 MUC5B MUC17 MUC1 MUC4 MUC5AC MUC6	1.61e-08	109	84	9	MM15164
Pathway	REACTOME_NEGATIVE_REGULATION_OF_TCF_DEPENDENT_SIGNALING_BY_DVL_INTERACTING_PROTEINS	DVL1 DVL3 CCDC88C	2.02e-06	5	84	3	M27447
Pathway	REACTOME_DISEASES_OF_METABOLISM	MUC21 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	2.24e-06	250	84	10	M27554
Pubmed	Mucin gene expression in human laryngeal epithelia: effect of laryngopharyngeal reflux.	MUC19 MUC16 MUC5B MUC12 MUC17 MUC1 MUC3A MUC4 MUC5AC MUC6	2.56e-21	18	109	10	18834073
Pubmed	Expression of Muc19/Smgc gene products during murine sublingual gland development: cytodifferentiation and maturation of salivary mucous cells.	MUC19 MUC16 MUC5B MUC5AC MUC6	1.65e-12	6	109	5	19110483
Pubmed	A central chaperone-like role for 14-3-3 proteins in human cells.	DLG5 RBM15 CLASP1 MAP4 TAB2 FAM117B FRYL WNK1 CEP170 CCDC88C DST MDN1 ALMS1 PLEKHG3 SEC24B KMT2A NR3C2 HECTD1 FOXK1	2.45e-11	861	109	19	36931259
Pubmed	A human MAP kinase interactome.	DOCK1 TPR RALGDS KRT5 KRT13 ANK3 MAP1A CLIP2 MUC12 WNK1 TSC22D1 USF3 DST MCM3AP MUC1	3.73e-11	486	109	15	20936779
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	DOCK1 ANK3 MAP4 ARHGEF38 SRF PEX14 PPHLN1 FAM117B FRYL ZNF362 CCDC57 KANSL3 CEP170 PHF2 TSC22D1 USF3 ATXN2 SETD5 PLEKHG3 CBFA2T2 VPS35L QSER1 HECTD1	1.91e-10	1489	109	23	28611215
Pubmed	Polymorphism of human mucin genes in chest disease: possible significance of MUC2.	MUC5B MUC1 MUC4 MUC5AC	4.55e-10	5	109	4	11062147
Pubmed	MUC1, MUC2, MUC4, MUC5AC and MUC6 expression in the progression of prostate cancer.	MUC1 MUC4 MUC5AC MUC6	4.55e-10	5	109	4	16475027
Pubmed	Genome-wide CRISPR screens identify novel regulators of wild-type and mutant p53 stability.	KRT5 DLG5 RBM15 MAP1A CLASP1 TOPBP1 TAB2 RAD54L2 SRCAP WNK1 KANSL3 ALMS1 MCM3AP UNK FOXK1	5.20e-10	588	109	15	38580884
Pubmed	HDLBP Promotes Hepatocellular Carcinoma Proliferation and Sorafenib Resistance by Suppressing Trim71-dependent RAF1 Degradation.	SECISBP2L DLG5 RBM15 CDSN SFSWAP VEZF1 CLASP1 CLIP2 MAP4 PPHLN1 SRPRB MAP3K1 KANSL3 CEP170 PHF2 ATXN2 MCM3AP SMARCA4 KMT2A MUC5AC RAD23B	1.54e-09	1371	109	21	36244648
Pubmed	PRISMA and BioID disclose a motifs-based interactome of the intrinsically disordered transcription factor C/EBPα.	RBM15 VEZF1 CLASP1 MAP4 ZNF362 RAD54L2 KANSL3 CEP170 PHF2 CELF1 HOXD13 ATXN2 SMARCA4 KMT2A ELF1 QSER1 FOXK1 RAD23B	1.01e-08	1103	109	18	34189442
Pubmed	Proteome-scale mapping of binding sites in the unstructured regions of the human proteome.	DOCK1 KLF12 ANK3 MAP1A PEX14 RAD54L2 WNK1 MAP3K1 USF3 ATXN2 CBFA2T2 UNK	1.16e-08	430	109	12	35044719
Pubmed	Aberrant expression of mucin core proteins and o-linked glycans associated with progression of pancreatic cancer.	MUC1 MUC4 MUC6	2.99e-08	3	109	3	23446997
Pubmed	Microbial products alter the expression of membrane-associated mucin and antimicrobial peptides in a three-dimensional human endocervical epithelial cell model.	MUC16 MUC1 MUC4	2.99e-08	3	109	3	23053434
Pubmed	Expression of mucin (MUC) genes in mucoepidermoid carcinoma.	MUC19 MUC1 MUC4	2.99e-08	3	109	3	21072847
Pubmed	Mucin expression in reactive gastropathy: an immunohistochemical analysis.	MUC1 MUC5AC MUC6	2.99e-08	3	109	3	17227128
Pubmed	Expression of mucin 3 and mucin 5AC in arthritic synovial tissue.	MUC3B MUC3A MUC5AC	2.99e-08	3	109	3	18163520
Pubmed	Regulation of membrane-associated mucins in the human corneal epithelial cells by dexamethasone.	MUC16 MUC1 MUC4	2.99e-08	3	109	3	17592322
Pubmed	Genomic organization and structure of the 3' region of human MUC3: alternative splicing predicts membrane-bound and soluble forms of the mucin.	MUC3B MUC17 MUC3A	2.99e-08	3	109	3	10512748
Pubmed	A comprehensive analysis of common genetic variation in MUC1, MUC5AC, MUC6 genes and risk of stomach cancer.	MUC1 MUC5AC MUC6	2.99e-08	3	109	3	19924550
Pubmed	Genome-wide bidirectional CRISPR screens identify mucins as host factors modulating SARS-CoV-2 infection.	MUC16 MUC1 MUC4	2.99e-08	3	109	3	35879412
Pubmed	Functional Consequences of Differential O-glycosylation of MUC1, MUC4, and MUC16 (Downstream Effects on Signaling).	MUC16 MUC1 MUC4	2.99e-08	3	109	3	27483328
Pubmed	Expression of the transmembrane mucins, MUC1, MUC4 and MUC16, in normal endometrium and in endometriosis.	MUC16 MUC1 MUC4	2.99e-08	3	109	3	24939955
Pubmed	The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.	DLG5 SFSWAP VEZF1 CLASP1 MAP4 TOPBP1 PPHLN1 PHF2 DST MDN1 ATXN2 SETD5 PLEKHG3 SEC24B TMEM266 KMT2A UNK FAM83D FOXK1 RAD23B	3.89e-08	1497	109	20	31527615
Pubmed	Prediction of the coding sequences of mouse homologues of KIAA gene: IV. The complete nucleotide sequences of 500 mouse KIAA-homologous cDNAs identified by screening of terminal sequences of cDNA clones randomly sampled from size-fractionated libraries.	SECISBP2L CLIP2 WNK1 CEP170 PHF2 CCDC88C TSC22D1 USF3 ALMS1 PLEKHG3 APPL1 HECTD1	5.21e-08	493	109	12	15368895
Pubmed	The in vivo Interaction Landscape of Histones H3.1 and H3.3.	VEZF1 TOPBP1 ZNF362 SRCAP PHF2 HOXD13 SMARCA4 KMT2A ELF1 QSER1 PHIP FOXK1 RAD23B	6.33e-08	608	109	13	36089195
Pubmed	Associations between the expression of mucins (MUC1, MUC2, MUC5AC and MUC6) and clinicopathologic parameters of human breast carcinomas.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	33154304
Pubmed	Gastric mucin expression in first-degree relatives of gastric cancer patients.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	24901817
Pubmed	Increased expression of MUC5AC and MUC5B promoting bacterial biofilm formation in chronic rhinosinusitis patients.	MUC5B MUC1 MUC5AC	1.20e-07	4	109	3	25638393
Pubmed	Evaluation of MUC1, MUC2, MUC5AC, and MUC6 Expression Differences in Lung Adenocarcinoma Subtypes by Using a Final Immunoreactivity Score (FIRS).	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	36367122
Pubmed	Epigenetic regulation (DNA methylation, histone modifications) of the 11p15 mucin genes (MUC2, MUC5AC, MUC5B, MUC6) in epithelial cancer cells.	MUC5B MUC5AC MUC6	1.20e-07	4	109	3	17471237
Pubmed	Expression of MUC1, MUC2, MUC5AC and MUC5B in mucinous lesions of the breast.	MUC5B MUC1 MUC5AC	1.20e-07	4	109	3	22269464
Pubmed	The mouse secreted gel-forming mucin gene cluster.	MUC5B MUC5AC MUC6	1.20e-07	4	109	3	14984930
Pubmed	Effects of the Helicobacter pylori Virulence Factor CagA and Ammonium Ion on Mucins in AGS Cells.	MUC5B MUC5AC MUC6	1.20e-07	4	109	3	29869461
Pubmed	Mucins in neoplastic spectrum of colorectal polyps: can they provide predictions?	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	20929551
Pubmed	Polymorphisms in MUC1, MUC2, MUC5B and MUC6 genes are not associated with the risk of chronic atrophic gastritis.	MUC5B MUC1 MUC6	1.20e-07	4	109	3	21596555
Pubmed	Prognostic significance of CDX2 and mucin expression in small intestinal adenocarcinoma.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	24603585
Pubmed	Expression of MUC2, MUC5AC, MUC5B, and MUC6 mucins in colorectal cancers and their association with the CpG island methylator phenotype.	MUC5B MUC5AC MUC6	1.20e-07	4	109	3	23807779
Pubmed	MUC1, MUC2, MUC5AC, and MUC6 in colorectal cancer: expression profiles and clinical significance.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	27298226
Pubmed	TRPV4 activation in human corneal epithelial cells promotes membrane mucin production.	MUC16 MUC1 MUC4	1.20e-07	4	109	3	39024979
Pubmed	Butyrate enemas upregulate Muc genes expression but decrease adherent mucus thickness in mice colon.	MUC17 MUC1 MUC4	1.20e-07	4	109	3	18198997
Pubmed	Mucin expression profile in Barrett's, dysplasia, adenocarcinoma sequence in the esophagus.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	17401217
Pubmed	Characterization of mouse muc6 and evidence of conservation of the gel-forming mucin gene cluster between human and mouse.	MUC5B MUC5AC MUC6	1.20e-07	4	109	3	12676567
Pubmed	Expression profile of mucins (MUC1, MUC2, MUC5AC, and MUC6) in ovarian mucinous tumours: changes in expression from benign to malignant tumours.	MUC1 MUC5AC MUC6	1.20e-07	4	109	3	25298197
Pubmed	Proximity biotinylation and affinity purification are complementary approaches for the interactome mapping of chromatin-associated protein complexes.	DLG5 RBM15 TOPBP1 ZNF362 SRCAP WNK1 CEP170 PHF2 DST ALMS1 KMT2A PHIP RAD23B	1.25e-07	645	109	13	25281560
Pubmed	Protein interaction network of the mammalian Hippo pathway reveals mechanisms of kinase-phosphatase interactions.	RBM15 CLASP1 FRYL WNK1 SRPRB CEP170 CCDC88C DST ALMS1 UNK HECTD1	1.70e-07	446	109	11	24255178
Pubmed	Multifaceted transcriptional regulation of the murine intestinal mucus layer by endogenous microbiota.	MUC17 MUC1 MUC4	2.98e-07	5	109	3	18035521
Pubmed	Differential expression of MUC genes in endometrial and cervical tissues and tumors.	MUC5B MUC1 MUC5AC	2.98e-07	5	109	3	16188033
Pubmed	The Nse5/6-like SIMC1-SLF2 complex localizes SMC5/6 to viral replication centers.	TPR RBM15 SFSWAP VEZF1 MAP4 TOPBP1 PPHLN1 ZNF362 CEP170 PHF2 ATXN2 SMARCA4 KMT2A QSER1 PHIP	3.09e-07	954	109	15	36373674
Pubmed	H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids.	RBM15 SFSWAP VEZF1 TOPBP1 PPHLN1 SRCAP SRPRB KANSL3 PHF2 DST MDN1 CELF1 SMARCA4 KMT2A QSER1 FOXK1 RAD23B	5.83e-07	1294	109	17	30804502
Pubmed	Large-scale characterization of HeLa cell nuclear phosphoproteins.	TPR RBM15 SFSWAP CLASP1 MAP4 KANSL3 MDN1 CBFA2T2 SMARCA4 KMT2A UNK APPL1 ELF1	9.77e-07	774	109	13	15302935
Pubmed	Characterization of an exchangeable gene trap using pU-17 carrying a stop codon-beta geo cassette.	DOCK1 RALGDS KLF12 CLASP1 PEX14 FRYL DNAJC6 CELF1 CLPTM1 ELF1 HECTD1	1.04e-06	536	109	11	15840001
Pubmed	Functional proteomics establishes the interaction of SIRT7 with chromatin remodeling complexes and expands its role in regulation of RNA polymerase I transcription.	TPR RBM15 MAP4 FRYL CEP170 DST MDN1 MCM3AP SMARCA4 KMT2A HECTD1 PHIP	1.04e-06	653	109	12	22586326
Pubmed	Exchangeable gene trap using the Cre/mutated lox system.	DOCK1 RALGDS KLF12 CLASP1 PEX14 FRYL DNAJC6 CELF1 CLPTM1 ELF1 HECTD1	1.07e-06	538	109	11	10512203
Pubmed	SRCAP complex promotes lung cancer progression by reprograming the oncogenic transcription of Hippo-YAP/TAZ signaling pathway.	TPR ANK3 MAP4 DVL1 SRCAP CEP170 ALMS1 SEC24B SMARCA4 KMT2A QSER1	1.31e-06	549	109	11	38280479
Pubmed	Identification of proximal SUMO-dependent interactors using SUMO-ID.	CDSN MAP1A MAP4 RAD54L2 KANSL3 CEP170 CELF1 MAVS SEC24B FOXK1	1.44e-06	444	109	10	34795231
Pubmed	G alpha o mediates WNT-JNK signaling through dishevelled 1 and 3, RhoA family members, and MEKK 1 and 4 in mammalian cells.	DVL1 DVL3 MAP3K1	1.66e-06	8	109	3	18187455
Pubmed	RNF43 inhibits WNT5A-driven signaling and suppresses melanoma invasion and resistance to the targeted therapy.	DLG5 ANK3 DVL1 DVL3 TAB2 ALMS1 ATXN2 SEC24B	1.89e-06	263	109	8	34702444
Pubmed	Targeting TRIM37-driven centrosome dysfunction in 17q23-amplified breast cancer.	DLG5 MAP1A MAP4 CEP170 ALMS1 MCM3AP SEC24B	1.96e-06	184	109	7	32908313
Pubmed	Spatiotemporal profile of postsynaptic interactomes integrates components of complex brain disorders.	TPR ANK3 CLASP1 CLIP2 NHSL2 DNAJC6 CEP170 CCDC88C DST MDN1 ATXN2 SMARCA4 APPL1 QSER1	1.98e-06	963	109	14	28671696
Pubmed	Fibril treatment changes protein interactions of tau and α-synuclein in human neurons.	TPR KRT13 CLASP1 MAP4 DVL1 DVL3 CEP170 DST CELF1 PHIP	3.98e-06	498	109	10	36634849
Pubmed	Interactomes of Glycogen Synthase Kinase-3 Isoforms.	DLG5 MAP1A CLASP1 DST ALMS1 UNK HECTD1	4.54e-06	209	109	7	36779422
Pubmed	GATA4 Controls Epithelial Morphogenesis in the Developing Stomach to Promote Establishment of Glandular Columnar Epithelium.	KRT5 KRT13 MUC5AC	4.85e-06	11	109	3	34111600
Pubmed	Spatiotemporal-resolved protein networks profiling with photoactivation dependent proximity labeling.	TPR SFSWAP WNK1 CEP170 CELF1 ATXN2 APPL1 QSER1 RAD23B	4.88e-06	399	109	9	35987950
Pubmed	Proteome-wide identification of HSP70/HSC70 chaperone clients in human cells.	DLG5 CDSN KRT13 CLASP1 MAP4 DVL3 PEX14 MUC5B FRYL WNK1 EZHIP CEP170 MAVS CLPTM1 FOXK1 RAD23B	5.67e-06	1367	109	16	32687490
Pubmed	Construction of expression-ready cDNA clones for KIAA genes: manual curation of 330 KIAA cDNA clones.	CLIP2 TAB2 WNK1 PHF2 DST ALMS1 APPL1	7.36e-06	225	109	7	12168954
Pubmed	MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.	KRT5 DLG5 RBM15 CDSN SFSWAP MAP1A VEZF1 CLASP1 MTMR1 SRCAP CEP170 PHF2 DST SMARCA4	7.53e-06	1082	109	14	38697112
Pubmed	N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective.	TPR MAP1A MAP4 PEX14 SRCAP WNK1 CEP170 DST ALMS1 MAVS SEC24B SMARCA4 KMT2A	7.55e-06	934	109	13	33916271
Pubmed	Macrophage/cancer cell interactions mediate hormone resistance by a nuclear receptor derepression pathway.	TAB2 MAP3K1 SMARCA4	8.37e-06	13	109	3	16469706
Pubmed	WNT/RYK signaling restricts goblet cell differentiation during lung development and repair.	KRT5 MUC5B MUC1 MUC5AC	9.32e-06	42	109	4	31776260
Pubmed	Cloning and analysis of cDNA encoding a major airway glycoprotein, human tracheobronchial mucin (MUC5).	MUC5B MUC5AC	9.73e-06	2	109	2	7513696
Pubmed	Mucins: a biologically relevant glycan barrier in mucosal protection.	MUC21 MUC12	9.73e-06	2	109	2	24821013
Pubmed	Airway mucin MUC5AC and MUC5B concentrations and the initiation and progression of chronic obstructive pulmonary disease: an analysis of the SPIROMICS cohort.	MUC5B MUC5AC	9.73e-06	2	109	2	34058148
Pubmed	The association between MUC5AC and MUC5B genes expression and remodeling progression in severe neutrophilic asthma: A direct relationship.	MUC5B MUC5AC	9.73e-06	2	109	2	37146737
Pubmed	MUC5AC and MUC5B Mucins Are Decreased in Cystic Fibrosis Airway Secretions.	MUC5B MUC5AC	9.73e-06	2	109	2	14988081
Pubmed	The Dishevelled-associating protein Daple controls the non-canonical Wnt/Rac pathway and cell motility.	DVL1 CCDC88C	9.73e-06	2	109	2	22643886
Pubmed	Mucin glycosylation changes in cystic fibrosis lung disease are not manifest in submucosal gland secretions.	MUC5B MUC5AC	9.73e-06	2	109	2	15563276
Pubmed	Alterations of the ocular surface epithelial MUC16 and goblet cell MUC5AC in patients with atopic keratoconjunctivitis.	MUC16 MUC5AC	9.73e-06	2	109	2	18782111
Pubmed	Initiation of transcription of the MUC3A human intestinal mucin from a TATA-less promoter and comparison with the MUC3B amino terminus.	MUC3B MUC3A	9.73e-06	2	109	2	12958310
Pubmed	The expression of MUC5AC and MUC5B mucin genes in the mucosa of chronic rhinosinusitis and nasal polyposis.	MUC5B MUC5AC	9.73e-06	2	109	2	17621824
Pubmed	MUC4 and MUC5AC are highly specific tumour-associated mucins in biliary tract cancer.	MUC4 MUC5AC	9.73e-06	2	109	2	18475301
Pubmed	Enhanced discrimination of malignant from benign pancreatic disease by measuring the CA 19-9 antigen on specific protein carriers.	MUC16 MUC5AC	9.73e-06	2	109	2	22220206
Pubmed	Muc5b is required for airway defence.	MUC5B MUC5AC	9.73e-06	2	109	2	24317696
Pubmed	Translocation (4;11)(p12;q23) with rearrangement of FRYL and MLL in therapy-related acute myeloid leukemia.	FRYL KMT2A	9.73e-06	2	109	2	17854671
Pubmed	Usefulness of tumor markers CA 125 and CA 15.3 at diagnosis and during follow-up in non-Hodgkin's lymphoma: study of 200 patients.	MUC16 MUC1	9.73e-06	2	109	2	16194893
Pubmed	Genetic and Transcriptomic Bases of Intestinal Epithelial Barrier Dysfunction in Inflammatory Bowel Disease.	MUC1 MUC4	9.73e-06	2	109	2	28885228
Pubmed	Macrophages are related to goblet cell hyperplasia and induce MUC5B but not MUC5AC in human bronchus epithelial cells.	MUC5B MUC5AC	9.73e-06	2	109	2	22391959
Pubmed	C-Mannosylation of MUC5AC and MUC5B Cys subdomains.	MUC5B MUC5AC	9.73e-06	2	109	2	14718370
Pubmed	Polymorphisms of MUC16 (CA125) and MUC1 (CA15.3) in relation to ovarian cancer risk and survival.	MUC16 MUC1	9.73e-06	2	109	2	24551091
Pubmed	Mucins MUC5AC and MUC5B Are Variably Packaged in the Same and in Separate Secretory Granules.	MUC5B MUC5AC	9.73e-06	2	109	2	35776514
Pubmed	Potential application of alternatively glycosylated serum MUC1 and MUC5AC in gastric cancer diagnosis.	MUC1 MUC5AC	9.73e-06	2	109	2	18848467
Pubmed	MUC1 contributes to goblet cell metaplasia and MUC5AC expression in response to cigarette smoke in vivo.	MUC1 MUC5AC	9.73e-06	2	109	2	32401676
Pubmed	The ocular surface phenotype of Muc5ac and Muc5b null mice.	MUC5B MUC5AC	9.73e-06	2	109	2	24327612
Pubmed	Role of mucins in the skin during benign and malignant conditions.	MUC1 MUC5AC	9.73e-06	2	109	2	21146919
Pubmed	Mucin production during prenatal and postnatal murine lung development.	MUC5B MUC5AC	9.73e-06	2	109	2	21653907
Pubmed	Clinicopathological features of superficial non-ampurally duodenal epithelial tumor; gastric phenotype of histology correlates to higher malignant potency.	MUC5AC MUC6	9.73e-06	2	109	2	28321513
Pubmed	Human mucin genes MUC2, MUC3, MUC4, MUC5AC, MUC5B, and MUC6 express stable and extremely large mRNAs and exhibit a variable length polymorphism. An improved method to analyze large mRNAs.	MUC5AC MUC6	9.73e-06	2	109	2	9422745
Pubmed	cDNA cloning of a human dishevelled DVL-3 gene, mapping to 3q27, and expression in human breast and colon carcinomas.	DVL1 DVL3	9.73e-06	2	109	2	9344861
Pubmed	Puerperal mastitis: a reproductive event of importance affecting anti-mucin antibody levels and ovarian cancer risk.	MUC16 MUC1	9.73e-06	2	109	2	23925696
Pubmed	MUC5B mobilizes and MUC5AC spatially aligns mucociliary transport on human airway epithelium.	MUC5B MUC5AC	9.73e-06	2	109	2	36427316
Pubmed	Mucins and Truncated O-Glycans Unveil Phenotypic Discrepancies between Serous Ovarian Cancer Cell Lines and Primary Tumours.	MUC16 MUC1	9.73e-06	2	109	2	30011875
Interaction	NUP43 interactions	RBM15 MAP4 DVL1 TOPBP1 MUC19 PPHLN1 RAD54L2 SRCAP KANSL3 PHF2 DST MAVS MCM3AP SMARCA4 KMT2A ELF1 PHIP	2.75e-08	625	106	17	int:NUP43
Interaction	YWHAH interactions	DLG5 RBM15 SFSWAP CLASP1 NHSL2 TAB2 PPHLN1 FAM117B FRYL WNK1 CEP170 CCDC88C DST ALMS1 PLEKHG3 SEC24B KMT2A APPL1 NR3C2 HECTD1 FOXK1	2.41e-07	1102	106	21	int:YWHAH
Interaction	YWHAZ interactions	DLG5 RBM15 CDSN CLASP1 RASGRF2 CLIP2 MTMR1 TAB2 FAM117B FRYL WNK1 MAP3K1 CEP170 CCDC88C DST PLEKHG3 ASXL3 KMT2A UNK APPL1 HECTD1 FOXK1	1.14e-06	1319	106	22	int:YWHAZ
Interaction	PML interactions	CDSN MAP1A MAP4 DVL3 TOPBP1 SRF RAD54L2 EZHIP KANSL3 CEP170 MDN1 CELF1 MAVS SEC24B SMARCA4 KMT2A PHIP FOXK1	1.66e-06	933	106	18	int:PML
Interaction	YWHAG interactions	DLG5 RBM15 CLASP1 NHSL2 TAB2 FAM117B FRYL WNK1 MAP3K1 CEP170 CCDC88C DST MDN1 ALMS1 PLEKHG3 SEC24B KMT2A UNK APPL1 HECTD1 FOXK1	1.81e-06	1248	106	21	int:YWHAG
Interaction	DYRK1B interactions	EGLN2 PEX14 FAM117B RAD54L2 MAP3K1 FOXK1	8.52e-06	91	106	6	int:DYRK1B
Interaction	DCTN1 interactions	TPR KRT5 MAP1A CLASP1 MAP4 DVL1 PEX14 CEP170 CCDC88C DST FAM83D HECTD1	1.19e-05	497	106	12	int:DCTN1
Interaction	SFN interactions	MAP1A CLASP1 MAP4 TAB2 FAM117B FRYL WNK1 CEP170 CCDC88C DST ALMS1 PLEKHG3 KMT2A HECTD1	1.59e-05	692	106	14	int:SFN
Interaction	YWHAQ interactions	TPR DLG5 CDSN CLASP1 MAP4 TAB2 FAM117B FRYL WNK1 MAP3K1 CEP170 CCDC88C DST PLEKHG3 KMT2A APPL1 HECTD1 FOXK1	2.01e-05	1118	106	18	int:YWHAQ
Interaction	MAPRE3 interactions	DLG5 MAP1A CLASP1 CLIP2 MAP4 DVL1 CEP170 DST	2.94e-05	230	106	8	int:MAPRE3
Interaction	DYNLT1 interactions	TPR KLF12 CLASP1 NHSL2 DVL1 DST KMT2A HECTD1	4.10e-05	241	106	8	int:DYNLT1
Interaction	NFYC interactions	SRF KANSL3 USF3 DST ALMS1 KMT2A ELF1	4.20e-05	177	106	7	int:NFYC
Interaction	H3C3 interactions	VEZF1 TOPBP1 ZNF362 SRCAP PHF2 HOXD13 SMARCA4 KMT2A QSER1 PHIP RAD23B	5.97e-05	495	106	11	int:H3C3
Interaction	SMC5 interactions	TPR RBM15 SFSWAP VEZF1 MAP4 TOPBP1 PPHLN1 ZNF362 CEP170 PHF2 ATXN2 SMARCA4 KMT2A QSER1 HECTD1 PHIP	6.60e-05	1000	106	16	int:SMC5
Interaction	WWTR1 interactions	ANK3 DVL1 DVL3 SRCAP CEP170 ALMS1 SEC24B SMARCA4 KMT2A QSER1	7.75e-05	422	106	10	int:WWTR1
Interaction	CEBPA interactions	RBM15 VEZF1 CLASP1 MAP4 ZNF362 RAD54L2 KANSL3 CEP170 PHF2 CELF1 HOXD13 ATXN2 SMARCA4 KMT2A ELF1 QSER1 FOXK1 RAD23B	8.18e-05	1245	106	18	int:CEBPA
Interaction	CLASP1 interactions	TPR CLASP1 CLIP2 MAP4 ARHGEF38 HECTD1	9.00e-05	138	106	6	int:CLASP1
Interaction	EPB41L4A interactions	DLG5 ANK3 DVL1 DVL3 DST MDN1	9.74e-05	140	106	6	int:EPB41L4A
Interaction	H3-3A interactions	VEZF1 TOPBP1 ZNF362 SRCAP PHF2 HOXD13 SMARCA4 KMT2A ELF1 QSER1 PHIP FOXK1 RAD23B	1.53e-04	749	106	13	int:H3-3A
Interaction	ELF2 interactions	KLF12 SRCAP KANSL3 KMT2A ELF1 FOXK1	1.76e-04	156	106	6	int:ELF2
Interaction	KCNA3 interactions	DOCK1 TPR DLG5 ANK3 MAP4 MTMR1 TAB2 SRPRB CEP170 CCDC88C DST SEC24B SMARCA4 KMT2A	1.88e-04	871	106	14	int:KCNA3
Interaction	FOXK2 interactions	TPR DVL3 KANSL3 HOXD13 ASXL3 ELF1 FOXK1	1.88e-04	225	106	7	int:FOXK2
Interaction	SKAP1 interactions	MTMR1 PPHLN1 ALMS1 ATXN2 SETD5	2.03e-04	102	106	5	int:SKAP1
Interaction	KDM6A interactions	SRF KANSL3 ASXL3 SMARCA4 KMT2A FOXK1	2.16e-04	162	106	6	int:KDM6A
Interaction	TSC22D1 interactions	WNK1 SRPRB TSC22D1 MCM3AP UNK	2.23e-04	104	106	5	int:TSC22D1
Interaction	DRC3 interactions	MUC19 ALMS1 FAM83D	2.32e-04	23	106	3	int:DRC3
Interaction	NFYA interactions	VEZF1 DVL3 TOPBP1 SRF ELF1	2.33e-04	105	106	5	int:NFYA
Cytoband	7q22	MUC3B MUC12 MUC3A	1.03e-04	38	109	3	7q22
Cytoband	3q22.1	TOPBP1 SRPRB H1-8	1.40e-04	42	109	3	3q22.1
GeneFamily	CD molecules\|Mucins	MUC21 MUC3B MUC19 MUC16 MUC5B MUC12 MUC17 MUC22 MUC1 MUC3A MUC4 MUC5AC MUC6	1.15e-27	21	66	13	648
GeneFamily	Dishevelled segment polarity proteins\|PDZ domain containing	DVL1 DVL3	7.84e-05	4	66	2	505
GeneFamily	X-linked mental retardation\|Rho GTPase activating proteins\|BAR-PH domain containing	APPL1 ACAP3	1.72e-03	17	66	2	1291
GeneFamily	Pleckstrin homology domain containing\|Rho guanine nucleotide exchange factors\|C2 domain containing	RASGRF2 ARHGEF38 PLEKHG3	1.80e-03	66	66	3	722
GeneFamily	WD repeat domain containing\|DDB1 and CUL4 associated factors	DCAF10 PHIP	1.93e-03	18	66	2	498
Coexpression	NABA_ECM_AFFILIATED	MUC21 MUC19 MUC16 MUC5B MUC12 MUC17 MUC22 MUC1 MUC3A MUC4 MUC5AC MUC6	6.09e-12	170	108	12	M5880
Coexpression	NABA_ECM_AFFILIATED	MUC21 MUC19 MUC16 MUC5B MUC17 MUC1 MUC4 MUC5AC MUC6	1.96e-08	158	108	9	MM17063
Coexpression	GSE21927_C26GM_VS_4T1_TUMOR_MONOCYTE_BALBC_DN	KLF12 EGLN2 VEZF1 CLASP1 FRYL TSC22D1 CBFA2T2 ELF1	1.76e-06	199	108	8	M7607
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_DN	SECISBP2L DOCK1 VEZF1 CLASP1 TOPBP1 PEX14 TAB2 FRYL CEP170 DST MDN1 ATXN2 SEC24B PHIP RAD23B	2.35e-06	856	108	15	M4500
Coexpression	DACOSTA_UV_RESPONSE_VIA_ERCC3_COMMON_DN	CLASP1 TOPBP1 TAB2 FRYL CEP170 DST MDN1 ATXN2 SEC24B PHIP RAD23B	3.65e-06	466	108	11	M13522
Coexpression	GSE21033_1H_VS_24H_POLYIC_STIM_DC_UP	RALGDS VEZF1 DNAJC6 MAP3K1 CBFA2T2 SEC24B QSER1	4.80e-06	161	108	7	M7728
Coexpression	BOSCO_EPITHELIAL_DIFFERENTIATION_MODULE	MUC21 KRT13 MUC16 MUC1 MUC4	9.86e-06	69	108	5	M2533
Coexpression	GSE7768_OVA_ALONE_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	RBM15 PHF2 PHKA2 PLEKHG3 POC1B FAM83D QSER1	1.03e-05	181	108	7	M6857
Coexpression	NABA_MATRISOME_ASSOCIATED	EGLN2 MUC21 MUC19 MUC16 MUC5B MUC12 MUC17 MUC22 MUC1 MUC3A MUC4 MUC5AC MUC6	1.33e-05	751	108	13	M5885
Coexpression	GSE11057_EFF_MEM_VS_CENT_MEM_CD4_TCELL_DN	SERTAD2 FAM117B MAP3K1 USF3 MDN1 KMT2A PHIP	1.37e-05	189	108	7	M3112
Coexpression	GSE21927_SPLEEN_C57BL6_VS_EL4_TUMOR_BALBC_MONOCYTES_UP	KLF12 CLASP1 TSC22D1 ALMS1 CBFA2T2 KMT2A ELF1	1.91e-05	199	108	7	M7596
Coexpression	GSE13306_RA_VS_UNTREATED_TREG_DN	RBM15 MAP4 SERTAD2 RAD54L2 PLEKHG3 ASXL3 NEURL1B	1.97e-05	200	108	7	M3233
Coexpression	NAKAYA_PBMC_FLUARIX_FLUVIRIN_AGE_18_50YO_CORRELATED_WITH_HAI_28DY_RESPONSE_AT_7DY_NEGATIVE	KLF12 ANK3 SFSWAP CLASP1 FAM117B MAP3K1 USF3 UNK ELF1 HECTD1	2.71e-05	474	108	10	M40991
Coexpression	BUYTAERT_PHOTODYNAMIC_THERAPY_STRESS_UP	SECISBP2L RALGDS KLF12 EGLN2 SFSWAP CLIP2 TSC22D1 DST CELF1 SETD5 CBFA2T2 SEC24B ELF1	3.42e-05	822	108	13	M6782
Coexpression	DAZARD_RESPONSE_TO_UV_NHEK_DN	CLASP1 SERTAD2 FRYL CEP170 DST CBFA2T2 ELF1 PHIP	3.51e-05	300	108	8	M8702
Coexpression	LIU_PROSTATE_CANCER_DN	KRT5 KRT13 NHSL2 PEX14 DST HOXD13 FAM83D NR3C2 NEURL1B MUC4	3.78e-05	493	108	10	M19391
Coexpression	HOEBEKE_LYMPHOID_STEM_CELL_UP	DOCK1 TPR SETD5 MCM3AP SMARCA4	5.16e-05	97	108	5	M14698
Coexpression	DURANTE_ADULT_OLFACTORY_NEUROEPITHELIUM_OLFACTORY_HORIZONTAL_BASAL_CELLS	KRT5 TSC22D1 DST	6.28e-05	19	108	3	M39272
Coexpression	GSE7768_OVA_WITH_LPS_VS_OVA_WITH_MPL_IMMUNIZED_MOUSE_WHOLE_SPLEEN_6H_UP	MAP3K1 PHF2 PHKA2 ALMS1 QSER1 ACAP3	7.80e-05	171	108	6	M6853
Coexpression	NAKAYA_B_CELL_FLUMIST_AGE_18_50YO_7DY_UP	RALGDS ANK3 MAP4 MTMR1 FRYL CEP170 CCDC88C MAVS DCAF10	1.57e-04	475	108	9	M40979
Coexpression	GSE13738_TCR_VS_BYSTANDER_ACTIVATED_CD4_TCELL_DN	ANK3 TAB2 DNAJC6 KANSL3 NR3C2 ACAP3	1.74e-04	198	108	6	M3325
Coexpression	GSE21927_SPLENIC_VS_TUMOR_MONOCYTES_FROM_C26GM_TUMOROUS_MICE_BALBC_DN	KLF12 EGLN2 VEZF1 CLASP1 FRYL TSC22D1	1.74e-04	198	108	6	M7605
Coexpression	GSE15767_MED_VS_SCS_MAC_LN_DN	DLG5 SPN MAP4 RAD54L2 MDN1 APPL1	1.79e-04	199	108	6	M3585
Coexpression	GSE5503_PLN_DC_VS_SPLEEN_DC_ACTIVATED_ALLOGENIC_TCELL_UP	DOCK1 SERTAD2 DNAJC6 PLEKHG3 POC1B UNK	1.84e-04	200	108	6	M296
Coexpression	GSE27786_CD4_VS_CD8_TCELL_UP	SECISBP2L NHSL2 FRYL ZNF362 SRCAP TSC22D1	1.84e-04	200	108	6	M4819
Coexpression	LAKE_ADULT_KIDNEY_C14_DISTAL_CONVOLUTED_TUBULE	KLF12 ANK3 CLASP1 WNK1 DST NR3C2	2.27e-04	208	108	6	M39233
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#4_top-relative-expression-ranked_1000	DOCK1 TPR KLF12 ANK3 SFSWAP WNK1 SETD5 ASXL3 SEC24B PHIP	2.52e-05	385	107	10	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k4
CoexpressionAtlas	BM Top 100 - trachea	KRT5 KRT13 MUC16 MUC4 MUC5AC	3.16e-05	72	107	5	BM Top 100 - trachea
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_top-relative-expression-ranked_1000	DOCK1 TPR KRT5 KLF12 ANK3 SFSWAP MAP4 WNK1 DNAJC6 HOXD13 SETD5 ASXL3 SEC24B PHIP	6.22e-05	818	107	14	gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000
CoexpressionAtlas	DevelopingGonad_e11.5_testes_emap-3226_top-relative-expression-ranked_1000	SFSWAP CLASP1 NHSL2 SERTAD2 ZNF362 SRPRB EBF2 ATXN2 ASXL3 SEC24B VPS35L SMARCA4 PHIP RAD23B	8.57e-05	843	107	14	gudmap_developingGonad_e11.5_testes_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k-means-cluster#3_top-relative-expression-ranked_1000	DOCK1 TPR KLF12 ANK3 CLASP1 SERTAD2 CELF1 SETD5 PHIP	1.05e-04	369	107	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_k3_1000
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_1000	DOCK1 TPR KRT5 KLF12 ANK3 CLASP1 MAP4 SERTAD2 DST CELF1 HOXD13 SETD5 PHIP	2.08e-04	806	107	13	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_1000
CoexpressionAtlas	DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500	KLF12 SFSWAP CLASP1 MAP4 NHSL2 SRCAP ATXN2 ASXL3 RAD23B	2.15e-04	406	107	9	gudmap_developingGonad_e16.5_epididymis_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_top-relative-expression-ranked_500	KRT5 KLF12 ANK3 SERTAD2 DST CELF1 HOXD13 SETD5 PHIP	2.23e-04	408	107	9	DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30902_500
CoexpressionAtlas	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_top-relative-expression-ranked_1000	DOCK1 KRT5 KLF12 CLASP1 MAP4 DNAJC6 CEP170 CELF1 HOXD13 SETD5 ASXL3 APPL1 PHIP	2.40e-04	818	107	13	DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-6689_1000
CoexpressionAtlas	DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500	KLF12 SFSWAP CLASP1 MAP4 NHSL2 SRCAP ATXN2 ASXL3 RAD23B	2.44e-04	413	107	9	gudmap_developingGonad_e14.5_ epididymis_500
CoexpressionAtlas	DevelopingGonad_P2_epididymis_emap-30199_k-means-cluster#3_top-relative-expression-ranked_1000	KLF12 SFSWAP MAP4 SRCAP MAP3K1 ATXN2 RAD23B	2.70e-04	249	107	7	gudmap_developingGonad_P2_epididymis_1000_k3
ToppCell	NS-control\|NS / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	KRT5 DLG5 ANK3 MUC16 TSC22D1 DST MUC1 HECTD1 MUC4	1.51e-09	200	108	9	ecbe89ff95d046155b984c8c150e0b9e7278f839
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC21 KRT13 MUC16 FAM83D MUC22 MUC1 MUC4 MUC5AC	1.13e-08	175	108	8	8252ddc2ca95071381f0354aefb70c4714828491
ToppCell	3'-Distal_airway-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC21 KRT13 MUC16 FAM83D MUC22 MUC1 MUC4 MUC5AC	1.13e-08	175	108	8	8ccf60fc469059d7aaf4e6ce54159db2962e0060
ToppCell	Bronchus_Control_(B.)-Epithelial-TX\|Bronchus_Control_(B.) / Sample group, Lineage and Cell type	KRT5 ANK3 MUC16 MUC5B TSC22D1 MUC1 MUC4 MUC5AC	3.19e-08	200	108	8	f5bc7d30aa03dd0f95eb64255bd1a2543be8d327
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	KRT5 KRT13 MUC16 KCND1 MUC1 MUC3A MUC4	2.30e-07	174	108	7	207aa0118633cbe9a65839bbb1bb3ba9f8118ad2
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.5\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	DLG5 ANK3 ARHGEF38 MUC16 MUC5B MUC4 MUC5AC	2.79e-07	179	108	7	6e965e424eebef50f0202cff75f458be395cfca1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF38 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	3.36e-07	184	108	7	01c19a830348ab0b9c02c1546a439de70ee10f97
ToppCell	Severe_COVID-19-Epithelial-undefined_Epi\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	KRT13 MUC16 MUC5B TSC22D1 MUC1 MUC4 MUC5AC	4.03e-07	189	108	7	8cbd35320c7e7ff013ef0c0f13f8d875db1c53cd
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF38 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	4.17e-07	190	108	7	23f2ac4da431211084bb6ab0494c2e0b69547cb6
ToppCell	COVID-19-Epithelial_cells-Airway_goblet\|COVID-19 / group, cell type (main and fine annotations)	ANK3 ARHGEF38 MUC16 MUC5B MUC1 MUC4 MUC5AC	4.17e-07	190	108	7	51ca9ef4df3220487152fcf684147730637c7cc1
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ARHGEF38 MUC16 MUC5B MUC1 MUC4 MUC5AC MUC6	4.17e-07	190	108	7	3c337374d89e69cc0a78e65a4a7e21db7b050fcd
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC21 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.14e-07	196	108	7	a4d05d85fbafa869df19bba3881020ea433d81fb
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club-\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC21 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.14e-07	196	108	7	91a3c3091064f1f5a3bdc1dd5883fc24dce8ff05
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC21 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.14e-07	196	108	7	e819088a74d29e958371aa851ac9c74ec55367b7
ToppCell	BAL-Mild-Epithelial-Epithelial-Basal/Club\|Mild / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC21 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.14e-07	196	108	7	e675d661b6494ac3a85ba7ee5bdeaa98b8bbe957
ToppCell	Mild_COVID-19-Epithelial-Basal/Club\|Mild_COVID-19 / Disease group,lineage and cell class （2021.01.30）	MUC21 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.32e-07	197	108	7	4cc5b778e1e2c6c149160fa147c172977c0fa8eb
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 CDSN MUC16 MUC5B MUC1 MUC4 MUC5AC	5.51e-07	198	108	7	5dd2aa7684c36beffa204ca4c04d0501cabac10f
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	d04062d86643e5712cc2f519f4f36e643d404a16
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT5 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	a3f83fe5c3c557cd3ef8f5632f7fba5cf1859937
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	644197ff7e3299587881dd678836262e670ed4a8
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	ARHGEF38 MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	7223f853335492ca617dbec3e4b6872a8a463a45
ToppCell	Bronchial_Biopsy-Epithelial\|Bronchial_Biopsy / Tissue, Lineage and Cell class of Lung Cells from 10X	KRT5 ANK3 MUC16 TSC22D1 MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	ef5d8917c8d011184830a0b8197afc6266707b37
ToppCell	Severe_COVID-19-Epithelial-Basal/Club\|Severe_COVID-19 / Disease group,lineage and cell class （2021.01.30）	KRT5 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	2a0aebcfadff4e2dfc8244ad8a87c338ecccacfd
ToppCell	BAL-Severe-Epithelial-Epithelial-Basal/Club-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	5.70e-07	199	108	7	fd364f43859b2e7a3e91ce6a1c430cc42ad26a49
ToppCell	control\|World / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls	KRT5 DLG5 ANK3 DST MUC1 HECTD1 MUC4	5.89e-07	200	108	7	97f36d2c197e03d93a1fc59949d77ae90f6e6a9a
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT13 MUC16 FAM83D MUC1 MUC4 MUC5AC	3.83e-06	171	108	6	25c1979e972c959e1ce4c57804f976f53a247ad7
ToppCell	cellseq2-Epithelial-Epithelial_Glandular-Goblet\|cellseq2 / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	KRT13 MUC16 FAM83D MUC1 MUC4 MUC5AC	3.83e-06	171	108	6	fe27bf581c75ef33c2848878e51ed16b275a4c8e
ToppCell	5'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-club_cell-Club_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 MUC16 CADM2 FAM83D MUC4 MUC5AC	4.24e-06	174	108	6	42f2ba54b4ea4c62482582b0ccdadffae0a5eb4a
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	4.83e-06	178	108	6	9a3ef66814dfca7b37024e7f79e86ea8c72ae10f
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi-\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	4.83e-06	178	108	6	b413a634283550fa224db7d0d05956e3f64694a1
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	4.83e-06	178	108	6	49a2271718637522f74334068d252963ee13b1ce
ToppCell	BAL-Severe-Epithelial-Epithelial-undefined_Epi\|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT13 MUC16 MUC5B MUC1 MUC4 MUC5AC	4.83e-06	178	108	6	19b5432aa1d7f616d58a106543c18cf2d7ca840c
ToppCell	nucseq-Epithelial-Epithelial_Glandular\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC	4.99e-06	179	108	6	859cd8ee414ad6207c046ada2e655e49322dd01c
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC	5.15e-06	180	108	6	3dc80bc636bf0e6ffc9762853132a9fe59fd1f66
ToppCell	nucseq-Epithelial-Epithelial_Glandular-Goblet-Goblet\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC	5.15e-06	180	108	6	668a2d8e1d5a390309d5eb62c836f5903144bea9
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC21 KRT13 MUC5B MUC22 MUC1 MUC4	5.31e-06	181	108	6	faff2a34e391d053a17c926540e6cb46d94dd629
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	MUC21 KRT13 MUC5B MUC22 MUC1 MUC4	5.31e-06	181	108	6	5a9c332c0bf07cc20eaf8cf77b45e73668a6467d
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)	MUC21 KRT13 MUC5B MUC22 MUC1 MUC4	5.31e-06	181	108	6	488a517f6e5543b648a2e72e0e04332fad776de6
ToppCell	BAL-Control-Epithelial-Epithelial-Basal/Club\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	MUC21 KRT13 MUC5B MUC22 MUC1 MUC4	5.31e-06	181	108	6	58651853f9c715075889856793df66ebe00c04f1
ToppCell	Control-Epithelial_cells-Airway_mucous\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC	5.66e-06	183	108	6	15d24a4fb1ffe6cbafbd54fcd7dde9ddcfbe03b2
ToppCell	Control-Epithelial_cells-Airway_goblet\|Control / group, cell type (main and fine annotations)	MUC16 MUC5B MUC17 MUC3A MUC4 MUC5AC	5.84e-06	184	108	6	d92a71441e4e19f8c301999d8186f8e48e3cd162
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	6.60e-06	188	108	6	5901b276f2379abf486b8285957277e95f08464e
ToppCell	COVID-19-lung-Secretory\|lung / Disease (COVID-19 only), tissue and cell type	KRT5 ANK3 ARHGEF38 MUC5B MUC4 MUC5AC	6.81e-06	189	108	6	84d48e3ed25bebb8bb8074b3a2c5e2e88cff7f25
ToppCell	Enterocyte_Progenitors-C_06\|Enterocyte_Progenitors / shred on cell type and cluster	MUC5B MUC12 MUC1 MUC4 MUC5AC MUC6	7.45e-06	192	108	6	b9938e1a929c00628cc6ebfdf10cf285167f445c
ToppCell	COVID-19-lung-Secretory\|COVID-19 / Disease (COVID-19 only), tissue and cell type	KRT5 ANK3 ARHGEF38 MUC5B MUC4 MUC5AC	7.45e-06	192	108	6	59261098ccb52306f837f632ebaea45b90ad30fe
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.1\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC21 MUC16 FAM83D MUC1 MUC4 MUC5AC	7.67e-06	193	108	6	605fc2a25ed6846fb283b2918cfed98df6039d6b
ToppCell	C_06\|World / shred on cell type and cluster	MUC5B CCDC57 MUC1 MUC4 MUC5AC MUC6	7.90e-06	194	108	6	5cb42e09f380c4468cdc603ec0c3de35eadd3213
ToppCell	normal_Lung-Epithelial_cells-Club\|normal_Lung / Location, Cell class and cell subclass	MUC21 MUC5B TSC22D1 MUC1 MUC4 MUC5AC	8.14e-06	195	108	6	b46544ad5af04f4dbc2643637caa3d2d50d922ae
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Club\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 MUC21 MUC5B MUC1 MUC4 MUC5AC	8.14e-06	195	108	6	b9e8f405f6d837bb39b615836d3e2df349737c0e
ToppCell	Bronchial-NucSeq-Epithelial-Epi_airway_secretory\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SECISBP2L ANK3 MUC16 MUC5B MUC4 MUC5AC	8.14e-06	195	108	6	e7230a849ea31e6eef9bc6f5468938499450582d
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	8.38e-06	196	108	6	c18874f37b90e6afacc562b2082b67ea8a7cb4a4
ToppCell	COVID-19-Epithelial-Club,_Basal_cells\|COVID-19 / Condition, Lineage and Cell class	KRT5 MUC16 MUC5B MUC1 MUC4 MUC5AC	8.38e-06	196	108	6	dd32046067d93b9484cfbf1d7826a436a3d9f0e9
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	8.38e-06	196	108	6	a52879a4c822c5e4be569f01f845a795e00c5f4b
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	8.38e-06	196	108	6	7a4d502550e9e37dc42f2ff1be3c896afe365d7f
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.0.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	8.38e-06	196	108	6	60ea673ed887fe3890c5cf4ff4165384b76d7361
ToppCell	10x_3'_v2v3-Neoplastic-Stem-like-NPC-like-NPC-like_OPC-F\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MUC12 CADM2 TSC22D1 HOXD13 FAM83D ACAP3	8.62e-06	197	108	6	d9a5b6171867de21d4ef12aa5a802fb4de9e0c00
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC21 KRT13 MUC16 MUC1 MUC4 MUC5AC	8.62e-06	197	108	6	ac9c0c25cfeaabd53d332982c73fc6c47b0c6478
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Epithelial\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	MUC21 KRT13 MUC16 MUC1 MUC4 MUC5AC	8.62e-06	197	108	6	b57d2e3413ef6dd1da56c45087926f2f3eab876c
ToppCell	Parenchymal-10x5prime-Epithelial-Epi_airway_basal-Suprabasal\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 MUC16 MUC5B CADM2 ASXL3 MUC4	8.87e-06	198	108	6	de5987588b9fa9ee8c595ba06d7d844ead0e3c74
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2-\|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01)	KRT5 MUC21 KRT13 MUC16 MUC4 MUC6	8.87e-06	198	108	6	a54ae5275a510b49d7629f0908817a0c5f05020e
ToppCell	Lung_Parenchyma-Control-Epithelial-Epithelial-Basal_2\|Control / Location, Disease Group, Cell group, Cell class (2021.03.09)	KRT5 MUC21 KRT13 MUC16 MUC4 MUC6	8.87e-06	198	108	6	34997e3896d0893fbe51bfb0d4660ccaca1c975e
ToppCell	Parenchyma_Control_(B.)-Epithelial-TX-Basal_2\|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type	KRT5 MUC21 KRT13 MUC16 MUC4 MUC6	8.87e-06	198	108	6	686eda427b075e788de38149eae82faf19bd5704
ToppCell	Parenchymal-10x3prime_v2-Epithelial-Epi_airway_secretory\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 MUC21 MUC5B MUC1 MUC4 MUC5AC	9.13e-06	199	108	6	a8bfc0b93ad9968cf52a25be86995ffe436bd636
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	9.13e-06	199	108	6	70c0b9cff195d3d24e98443a729e211cac20c90f
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L MUC21 KRT13 MUC1 HECTD1 MUC4	9.13e-06	199	108	6	5a1557fe35aa48080d4967e8724bf27f9585a5fb
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L MUC21 KRT13 MUC1 HECTD1 MUC4	9.13e-06	199	108	6	0a657475b92aa3a713da62da364525249fdc3886
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell-Epi-Squamous\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L MUC21 KRT13 MUC1 HECTD1 MUC4	9.13e-06	199	108	6	a8f4bd0e65f36b29535864fae4347369d5c864d2
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M\|organoid_Kanton_Nature / Sample Type, Dataset, Time_group, and Cell type.	CLASP1 RAD54L2 CEP170 DST FOXK1 MIR9-1HG	9.13e-06	199	108	6	b2d7dea11207cca63d688f8051143850b29dbdf0
ToppCell	Bronchial-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	9.13e-06	199	108	6	ec1e110671e7725f752163c7241dbbf638dec2b2
ToppCell	(03)_KRT6B+-(1)_GFP\|(03)_KRT6B+ / shred by cell type by condition	RALGDS KRT5 KRT13 MUC5B NEURL1B MUC4	9.13e-06	199	108	6	10493933a3dc330e40595ec0c001428b9d68f17e
ToppCell	Tracheal-10x5prime-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	9.13e-06	199	108	6	e03bdc7cb825e287f41b834ec6061d23c1c03b04
ToppCell	saliva-Severe-critical_progression_d28-40-Epithelial-Epithelial,_Airway-squamous_epithelial_cell\|Severe-critical_progression_d28-40 / Compartment, severity and other cell annotations on 10x 3' data (130k)	SECISBP2L MUC21 KRT13 MUC1 HECTD1 MUC4	9.13e-06	199	108	6	eacea42e973f073b410f54c0a1b3a7f2dc2b5a29
ToppCell	Bronchial-10x5prime-Epithelial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	KRT5 ANK3 ARHGEF38 MUC16 MUC1 MUC4	9.40e-06	200	108	6	d3ee5f79513e2ac02ad3329b59e6290d457c44d2
ToppCell	Nasal_Brush-Epithelial\|Nasal_Brush / Tissue, Lineage and Cell class of Lung Cells from 10X	ANK3 MUC16 TSC22D1 MUC1 MUC4 MUC5AC	9.40e-06	200	108	6	7911073119ee47a37b68b73fc54f063e902a5067
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-5w-Neuronal-Intermediate\|5w / Sample Type, Dataset, Time_group, and Cell type.	RALGDS DLG5 ANK3 CEP170 CELF1 KMT2A	9.40e-06	200	108	6	c92e4fc0442404481fcac623d691dae6215b852d
ToppCell	Tracheal-10x3prime_v2-Epithelial-Epi_airway_secretory-Secretory_Goblet\|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations	MUC16 MUC5B FAM83D MUC1 MUC4 MUC5AC	9.40e-06	200	108	6	133853d0f55c63ebe94dd54151f9f1f90650a0d8
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf-Oligodendrocyte.Tfr.Ctps_(Ctps)\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ADGRG4 FAM83D MUC1 MUC6	9.74e-06	55	108	4	0b62b4f438a493a30bddb99e1eadd20c92704ee9
ToppCell	Substantia_nigra-Macroglia-POLYDENDROCYTE-P1-P1_1-Trf\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ADGRG4 FAM83D MUC1 MUC6	9.74e-06	55	108	4	fa556ea954ea868a4b23e410f3b27d69e04794ee
ToppCell	P15-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 ARHGEF38 MUC5B CCDC88C MUC1	2.96e-05	147	108	5	aba44c7057096483c4293a7ebcf8ccc8baed0231
ToppCell	P15-Epithelial-epithelial_progenitor_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ANK3 ARHGEF38 MUC5B CADM2 MUC1	3.47e-05	152	108	5	00d5503d462cfa009fb4cac79ecee11725a18b9a
ToppCell	renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Transitional_Principal-Intercalated_Cell\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 OR7C1 STAC2 MUC22 MUC1	3.93e-05	156	108	5	a4b0e89255ea5d60198cb2b3e739981f9c9cf5c5
ToppCell	3'-Airway_Nasal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	ANK3 MUC16 MUC5B MUC1 MUC5AC	4.05e-05	157	108	5	c43f2e1ea53b375a7432f17f87cfef3b2261003d
ToppCell	3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.0\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	MUC16 MUC5B MUC1 MUC4 MUC5AC	4.30e-05	159	108	5	60b1f4dce2ce0911160fda17f137c064da31e2eb
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell-mature_NK_T_cell_l22\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SRF DNAJC6 NR3C2 MUC6	5.28e-05	166	108	5	bcdaab49bde5beba750b76fdcc3781a3c12c4fff
ToppCell	facs-Lung-24m-Hematologic-lymphocytic-mature_NK_T_cell\|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	ANK3 SRF DNAJC6 NR3C2 MUC6	5.28e-05	166	108	5	5e3b998d740b24f790fad37350d704ca0ea10b77
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4\|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)	ANK3 TAB2 FAM117B MAP3K1 EBF2	5.43e-05	167	108	5	ced6ed9b412739c6ced622523347c10295edbf53
ToppCell	3'-Pediatric_IBD-SmallIntestine-Epithelial-Tuft-related-Microfold_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	ARHGEF38 MUC5B MUC1 MUC5AC MUC6	5.75e-05	169	108	5	a54a8494c1feff29d77ab4737fcfabc84ace5c94
ToppCell	facs-Trachea-nan-24m-Epithelial-basal_epithelial_cell_of_tracheobronchial_tree\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT13 MUC5B MUC1 MUC4	6.08e-05	171	108	5	d2a10e94b0490120d1420b944302eb841f902c64
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)-\|367C / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF38 MUC5B MUC1 MUC4 MUC6	6.42e-05	173	108	5	c2d973356c40e0284fd3bd7733a164b141c66008
ToppCell	367C-Epithelial_cells-Epithelial-G_(Club-Clara_cells)\|367C / Donor, Lineage, Cell class and subclass (all cells)	ARHGEF38 MUC5B MUC1 MUC4 MUC6	6.42e-05	173	108	5	d8e965ff7e9b758876ec1521c1ccedd739e8d673
ToppCell	Children_(3_yrs)-Epithelial-lung_goblet_cell-D139\|Children_(3_yrs) / Lineage, Cell type, age group and donor	MUC16 MUC5B FAM83D MUC4 MUC5AC	6.42e-05	173	108	5	464267a2ff3f5c387b6c9c6fa4dab135a221f448
ToppCell	Adult-Epithelial-lung_goblet_cell-D231\|Adult / Lineage, Cell type, age group and donor	MUC16 MUC5B ASXL3 FAM83D MUC5AC	6.60e-05	174	108	5	7d2f802f493f19a068e097b2909a9000e2160266
ToppCell	wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3\|wk_15-18 / Celltypes from embryonic and fetal-stage human lung	KRT5 KRT13 MUC16 MUC1 MUC4	6.96e-05	176	108	5	8d9d0fb46c418b2067be58aec822e8c2b1561461
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	ANK3 MUC19 STAC2 ASXL3 NR3C2	7.54e-05	179	108	5	d3438fed0d85d5ed5afa8ff820c45143d77b6c0d
ToppCell	Ciliated_cells-A-Donor_07\|World / lung cells shred on cell class, cell subclass, sample id	MAP1A MUC16 MUC5B MUC4 MUC5AC	7.74e-05	180	108	5	d9be152773fe9f2160edad9246fa03c03afeafd6
ToppCell	Control-Epithelial_cells-Airway_club\|Control / group, cell type (main and fine annotations)	MUC21 ANK3 ARHGEF38 MUC1 MUC4	7.95e-05	181	108	5	c755d23dd9aabc717dc73e2b3fa99a1f751e6507
ToppCell	facs-Limb_Muscle-ForelimbandHindlimb\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT13 MAP4 SERTAD2 WNK1	8.81e-05	185	108	5	eb7d3c1363d5fedc611f9c1a91ea823de251355e
ToppCell	facs-Trachea-nan-24m-Epithelial\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT13 MUC5B MUC1 MUC4	9.04e-05	186	108	5	6c06163d7315f1c71b15fe76f2e696bf3fa73b67
ToppCell	facs-Trachea-nan-24m-Epithelial-nan\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	KRT5 KRT13 MUC5B MUC1 MUC4	9.04e-05	186	108	5	78e3b00eb347d1aa197671e31be9b0c6e4235760
ToppCell	Epithelial-C_(AT2)\|World / shred on cell class and cell subclass (v4)	SECISBP2L ANK3 SWT1 ARHGEF38 MUC1	9.04e-05	186	108	5	b7b1763fc52b4485d843a4a6727055e6c95ebad3
Computational	Neighborhood of RBM8A	VEZF1 CEP170 PHF2 CELF1 SETD5 KMT2A	9.62e-06	81	66	6	GCM_RBM8A
Computational	Neighborhood of SUFU	CEP170 PHF2 CELF1 KMT2A HECTD1	1.05e-04	77	66	5	GCM_SUFU
Computational	Neighborhood of DFFA	VEZF1 MTMR1 PHF2 CELF1 KMT2A HECTD1	1.34e-04	129	66	6	GCM_DFFA
Computational	Neighborhood of UBE2N	VEZF1 CEP170 PHF2 CELF1 KMT2A HECTD1	3.51e-04	154	66	6	GCM_UBE2N
Computational	Neighborhood of PPM1D	VEZF1 CEP170 CELF1	5.20e-04	26	66	3	GCM_PPM1D
Computational	Neighborhood of MYST2	VEZF1 CEP170 PHF2 CELF1 SETD5 QSER1	6.32e-04	172	66	6	GCM_MYST2
Computational	Neighborhood of ZNF198	VEZF1 CEP170 PHF2 CELF1 QSER1	7.38e-04	117	66	5	GCM_ZNF198
Drug	cellobiitol	MUC3B SPN MUC12 MUC1 MUC3A MUC4 MUC5AC	4.06e-10	37	108	7	CID000003871
Drug	rioprostil	MUC3B SPN MUC12 MUC1 MUC3A MUC5AC	8.12e-09	32	108	6	CID005311413
Drug	Gastrin tetrapeptide	MUC3B SPN MUC12 MUC1 MUC3A MUC5AC	1.33e-07	50	108	6	CID000005415
Drug	alpha-estradiol; Down 200; 0.01uM; MCF7; HG-U133A	SPN MAP4 TOPBP1 PEX14 WNK1 TSC22D1 ALMS1 ATXN2 VPS35L	4.61e-07	199	108	9	122_DN
Drug	Captopril [62571-86-2]; Down 200; 17.2uM; PC3; HT_HG-U133A	SECISBP2L TPR ANK3 SFSWAP MAP4 SMARCA4 KMT2A ELF1	2.25e-06	179	108	8	4585_DN
Drug	guanidine hydrochloride	MUC3B SPN MUC12 MUC1 MUC3A MUC4 MUC5AC	2.76e-06	129	108	7	CID000005742
Drug	inulin	MUC3B SPN MUC12 MUC1 MUC3A MUC4 MUC5AC	3.38e-06	133	108	7	CID000024763
Drug	Sulfamethazine sodium salt [1981-58-4]; Down 200; 13.4uM; PC3; HT_HG-U133A	TPR ANK3 MAP4 ARHGEF38 WNK1 KMT2A ELF1 MIR9-1HG	3.51e-06	190	108	8	4322_DN
Drug	Methapyrilene hydrochloride [135-23-9]; Down 200; 13.4uM; PC3; HT_HG-U133A	SECISBP2L TPR RALGDS MAP4 WNK1 KMT2A ELF1 RAD23B	3.64e-06	191	108	8	6644_DN
Drug	mucic acid	MUC3B SPN MUC12 MUC1 MUC3A MUC5AC	3.91e-06	88	108	6	CID000000607
Drug	Albendazole [54965-21-8]; Down 200; 15uM; HL60; HG-U133A	SFSWAP PEX14 C11orf24 RWDD2B MDN1 CELF1 ATXN2 SMARCA4	4.09e-06	194	108	8	1547_DN
Drug	2-propylpentanoic acid; Down 200; 500uM; MCF7; HT_HG-U133A	RALGDS SFSWAP MAP4 PEX14 SRCAP WNK1 DCAF10 ATXN2	4.25e-06	195	108	8	1665_DN
Drug	Flunisolide [3385-03-3]; Down 200; 9.2uM; MCF7; HT_HG-U133A	DOCK1 DVL3 PEX14 RAD54L2 SRCAP PHKA2 CBFA2T2 MIR9-1HG	4.25e-06	195	108	8	3923_DN
Drug	Cefepime hydrochloride [123171-59-5]; Down 200; 7.4uM; HL60; HT_HG-U133A	SECISBP2L TPR SFSWAP SPN WNK1 MAP3K1 KMT2A ELF1	4.25e-06	195	108	8	6159_DN
Drug	Fluoxetine hydrochloride [59333-67-4]; Up 200; 11.6uM; MCF7; HT_HG-U133A	MAP4 MUC5B RAD54L2 SRCAP MAP3K1 ALMS1 CBFA2T2 MIR9-1HG	4.41e-06	196	108	8	3314_UP
Drug	Mepenzolate bromide [76-90-4]; Down 200; 9.6uM; PC3; HT_HG-U133A	DOCK1 TPR RALGDS MAP4 WNK1 SMARCA4 KMT2A QSER1	4.58e-06	197	108	8	3748_DN
Drug	torcetrapib	TPR ANK3 MAP4 DST POC1B KMT2A APPL1 ELF1 NR3C2 HECTD1	5.40e-06	342	108	10	ctd:C483909
Drug	heparin pentasaccharide	MUC3B SPN MUC12 SMARCA4 MUC1 MUC3A MUC5AC	5.72e-06	144	108	7	CID000444410
Drug	Contact Lens Solutions	MUC16 MUC1	2.23e-05	2	108	2	ctd:D018639
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; PC3; HT_HG-U133A	SECISBP2L TPR SFSWAP MAP4 WNK1 KMT2A ELF1	3.12e-05	187	108	7	4302_DN
Drug	Neostigmine bromide [114-80-7]; Down 200; 13.2uM; PC3; HT_HG-U133A	SECISBP2L RALGDS SFSWAP MAP4 MTMR1 KMT2A ELF1	3.23e-05	188	108	7	6735_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; PC3; HT_HG-U133A	SECISBP2L TPR SFSWAP MAP4 WNK1 ALMS1 ELF1	3.46e-05	190	108	7	4306_DN
Drug	Solasodine [126-17-0]; Down 200; 9.6uM; PC3; HT_HG-U133A	TPR SFSWAP SPN MAP4 WNK1 ELF1 MUC1	3.82e-05	193	108	7	4305_DN
Drug	Medrysone [2668-66-8]; Down 200; 11.6uM; MCF7; HT_HG-U133A	TPR MAP4 WNK1 MAP3K1 CBFA2T2 KMT2A RAD23B	3.95e-05	194	108	7	4727_DN
Drug	Benfotiamine [22457-89-2]; Down 200; 8.6uM; PC3; HT_HG-U133A	TPR SFSWAP MAP4 WNK1 ALMS1 KMT2A ELF1	3.95e-05	194	108	7	4312_DN
Drug	Cinnarizine [298-57-7]; Down 200; 10.8uM; HL60; HG-U133A	SPN PEX14 PHF2 PHKA2 TSC22D1 ATXN2 SMARCA4	4.21e-05	196	108	7	1558_DN
Drug	SB 202190; Up 200; 1uM; MCF7; HT_HG-U133A	MAP4 DVL3 MUC5B RAD54L2 PHKA2 ALMS1 CBFA2T2	4.21e-05	196	108	7	7054_UP
Drug	Terconazole [67915-31-5]; Up 200; 7.6uM; HL60; HT_HG-U133A	ANK3 MAP1A MAP4 SRF CCDC57 KCND1 RAD23B	4.21e-05	196	108	7	2484_UP
Drug	Ethamsylate [2624-44-4]; Up 200; 15.2uM; MCF7; HT_HG-U133A	KRT13 ZNF362 RAD54L2 SRCAP MAP3K1 MCM3AP MUC1	4.21e-05	196	108	7	7335_UP
Drug	fluphenazine dihydrochloride; Down 200; 10uM; MCF7; HG-U133A	SPN DVL3 SRF PEX14 C11orf24 HOXD13 MUC1	4.35e-05	197	108	7	490_DN
Drug	Amyleine hydrochloride [532-59-2]; Up 200; 14.8uM; PC3; HG-U133A	SPN C11orf24 SRCAP ATXN2 PLEKHG3 KMT2A ELF1	4.35e-05	197	108	7	1909_UP
Drug	Practolol [6673-35-4]; Down 200; 15uM; HL60; HG-U133A	EGLN2 SFSWAP SRF PEX14 MCM3AP SMARCA4 ELF1	4.35e-05	197	108	7	1587_DN
Drug	AH23848 hemicalcium salt hydrate; Down 200; 1uM; MCF7; HT_HG-U133A	ANK3 DVL3 TAB2 CLPTM1 SMARCA4 MUC1 RAD23B	4.35e-05	197	108	7	6903_DN
Drug	Aminohippuric acid [61-78-9]; Up 200; 20.6uM; HL60; HT_HG-U133A	MAP4 ZNF362 PLEKHG3 CBFA2T2 MCM3AP MUC4 MIR9-1HG	4.35e-05	197	108	7	3076_UP
Drug	Selegiline hydrochloride [14611-52-0]; Up 200; 17.8uM; HL60; HT_HG-U133A	KLF12 ANK3 CLIP2 MAP4 SRF CCDC57 MUC1	4.35e-05	197	108	7	2465_UP
Drug	Azacyclonol [115-46-8]; Down 200; 15uM; HL60; HG-U133A	SFSWAP MCM3AP CLPTM1 SMARCA4 KMT2A ELF1 RAD23B	4.49e-05	198	108	7	2020_DN
Drug	Diazoxide [364-98-7]; Up 200; 17.4uM; MCF7; HT_HG-U133A	ARHGEF38 MTMR1 MUC5B PLEKHG3 KMT2A MUC5AC MIR9-1HG	4.49e-05	198	108	7	2214_UP
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; MCF7; HT_HG-U133A	DVL3 ZNF362 RAD54L2 SRCAP MAP3K1 PLEKHG3 CBFA2T2	4.49e-05	198	108	7	6031_DN
Drug	Sulfabenzamide [127-71-9]; Down 200; 14.4uM; MCF7; HT_HG-U133A	SECISBP2L RALGDS MAP4 WNK1 PHKA2 ATXN2 MUC1	4.49e-05	198	108	7	4979_DN
Drug	Disopyramide [3737-09-5]; Up 200; 11.8uM; MCF7; HT_HG-U133A	RALGDS MAP1A DVL3 SRCAP CBFA2T2 MUC1 MUC6	4.49e-05	198	108	7	7035_UP
Drug	Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	DOCK1 DLG5 DVL3 RAD54L2 ATXN2 PLEKHG3 QSER1	4.64e-05	199	108	7	4806_DN
Drug	Metanephrine hydrochloride DL [881-95-8]; Down 200; 17.2uM; PC3; HG-U133A	DOCK1 TPR PEX14 TAB2 ATXN2 SMARCA4 KMT2A	4.64e-05	199	108	7	1933_DN
Drug	Acetopromazine maleate salt [3598-37-6]; Up 200; 9uM; HL60; HG-U133A	SPN MAP4 SERTAD2 ARHGEF38 SRCAP CBFA2T2 MIR9-1HG	4.79e-05	200	108	7	1777_UP
Drug	Proadifen hydrochloride [62-68-0]; Down 200; 10.2uM; MCF7; HT_HG-U133A	SECISBP2L KRT13 ANK3 MAP4 SRCAP PHF2 CBFA2T2	4.79e-05	200	108	7	7165_DN
Drug	Boric Acids	MUC16 MUC1	6.67e-05	3	108	2	ctd:D001888
Drug	phenoxymethyl	NR3C2 HRH3	6.67e-05	3	108	2	CID000134735
Drug	forskolin; Up 200; 50uM; MCF7; HT_HG-U133A_EA	KRT13 MUC5B SRCAP MAP3K1 HOXD13 MUC5AC	1.05e-04	157	108	6	913_UP
Drug	Tn epitope	MUC3B SPN MUC3A MUC4	1.36e-04	55	108	4	CID000447272
Drug	BW-B 70C; Up 200; 31.6uM; MCF7; HT_HG-U133A_EA	SECISBP2L SPN SERTAD2 DNAJC6 TSC22D1 ELF1	1.57e-04	169	108	6	1132_UP
Drug	Etifenin [63245-28-3]; Down 200; 12.4uM; PC3; HT_HG-U133A	SECISBP2L TPR MAP4 WNK1 KMT2A ELF1	2.08e-04	178	108	6	3998_DN
Drug	ICI 182,780; Down 200; 0.01uM; MCF7; HT_HG-U133A	RALGDS SPN MAP4 PEX14 SRCAP WNK1	2.34e-04	182	108	6	1663_DN
Drug	Nimodipine [66085-59-4]; Up 200; 9.6uM; HL60; HT_HG-U133A	DLG5 ANK3 CLIP2 MAP4 MIR9-1HG HRH3	2.56e-04	185	108	6	3103_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR ANK3 SFSWAP MAP4 WNK1 KMT2A	2.71e-04	187	108	6	4323_DN
Drug	Ethotoin [86-35-1]; Down 200; 19.6uM; PC3; HT_HG-U133A	TPR MAP4 WNK1 ALMS1 KMT2A ELF1	2.79e-04	188	108	6	4545_DN
Drug	Triflupromazine hydrochloride [1098-60-8]; Up 200; 10.2uM; MCF7; HT_HG-U133A	SPN MAP4 RAD54L2 CBFA2T2 MUC5AC MIR9-1HG	2.79e-04	188	108	6	7466_UP
Drug	Dipyrone [5907-38-0]; Down 200; 12uM; PC3; HT_HG-U133A	TPR SFSWAP MAP4 SRCAP WNK1 ELF1	2.79e-04	188	108	6	4310_DN
Drug	Cloperastine hydrochloride [14984-68-0]; Down 200; 11uM; PC3; HT_HG-U133A	SECISBP2L TPR SFSWAP MAP4 WNK1 KMT2A	2.87e-04	189	108	6	4271_DN
Drug	MS-275; Down 200; 10uM; PC3; HT_HG-U133A	SFSWAP MAP4 SRF KMT2A ZFYVE26 RAD23B	2.87e-04	189	108	6	7074_DN
Drug	Daunorubicin hydrochloride [23541-50-6]; Down 200; 7uM; MCF7; HT_HG-U133A	RBM15 SERTAD2 TSC22D1 SEC24B ELF1 ZFYVE26	2.95e-04	190	108	6	4983_DN
Drug	PF-00562151-00 [351320-12-2]; Down 200; 10uM; MCF7; HT_HG-U133A	DVL3 PEX14 WNK1 CLPTM1 SMARCA4 MUC1	2.95e-04	190	108	6	6912_DN
Drug	thioridazine hydrochloride; Down 200; 10uM; PC3; HT_HG-U133A	DLG5 SPN SRCAP CBFA2T2 MCM3AP SMARCA4	3.03e-04	191	108	6	4454_DN
Drug	Pempidine tartrate [546-48-5]; Down 200; 13uM; MCF7; HT_HG-U133A	TPR MAP4 DVL3 WNK1 KMT2A ELF1	3.03e-04	191	108	6	3926_DN
Drug	N-Acetyl-DL-homocysteine Thiolactone [1195-16-0]; Down 200; 25.2uM; PC3; HT_HG-U133A	TPR KLF12 SFSWAP MAP4 WNK1 ELF1	3.12e-04	192	108	6	4311_DN
Drug	Deltaline [6836-11-9]; Down 200; 7.8uM; MCF7; HT_HG-U133A	MAP4 SRF RAD54L2 CBFA2T2 KMT2A RAD23B	3.12e-04	192	108	6	3925_DN
Drug	Trichostatin A, from Streptomyces sp.; Down 200; 0.1uM; HL60; HG-U133A	SPN MAP4 ALMS1 ATXN2 SMARCA4 RAD23B	3.12e-04	192	108	6	1971_DN
Drug	0179445-0000 [211246-22-9]; Up 200; 10uM; PC3; HT_HG-U133A	SFSWAP WNK1 MAP3K1 PLEKHG3 CBFA2T2 ELF1	3.21e-04	193	108	6	4289_UP
Drug	ikarugamycin; Down 200; 2uM; MCF7; HT_HG-U133A_EA	MAP4 DVL3 RAD54L2 ALMS1 CBFA2T2 ZFYVE26	3.21e-04	193	108	6	866_DN
Drug	Methylhydantoin-5-(L) [40856-73-3]; Down 200; 35uM; MCF7; HT_HG-U133A	EGLN2 MAP4 PEX14 MUC5B SRCAP DNAJC6	3.21e-04	193	108	6	3378_DN
Drug	Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A	TPR ANK3 MAP4 WNK1 PLEKHG3 ELF1	3.21e-04	193	108	6	4321_DN
Drug	AG-012559 [369370-06-9]; Up 200; 10uM; PC3; HT_HG-U133A	RALGDS WNK1 CCDC88C ALMS1 SMARCA4 RAD23B	3.21e-04	193	108	6	6920_UP
Drug	geldanamycin; Down 200; 1uM; MCF7; HT_HG-U133A	DVL3 MAP3K1 CCDC88C ALMS1 ZFYVE26 MUC1	3.21e-04	193	108	6	5588_DN
Drug	Decamethonium bromide [541-22-0]; Up 200; 9.6uM; HL60; HT_HG-U133A	KLF12 ANK3 MAP4 ARHGEF38 ZNF362 MUC1	3.21e-04	193	108	6	2933_UP
Drug	Sulpiride [15676-16-1]; Down 200; 11.8uM; PC3; HT_HG-U133A	TPR MTMR1 TAB2 PLEKHG3 SEC24B ELF1	3.21e-04	193	108	6	4566_DN
Drug	nordihydroguaiaretic acid; Down 200; 1uM; PC3; HT_HG-U133A	RALGDS EGLN2 DLG5 SPN MAP4 RAD54L2	3.30e-04	194	108	6	1223_DN
Drug	Chlortetracycline hydrochloride [64-72-2]; Down 200; 7.8uM; PC3; HT_HG-U133A	MTMR1 TAB2 MUC5B CBFA2T2 VPS35L MUC1	3.30e-04	194	108	6	6761_DN
Drug	lomustine; Down 200; 100uM; MCF7; HT_HG-U133A	KRT13 ANK3 SRCAP CCDC57 PHKA2 SMARCA4	3.30e-04	194	108	6	7089_DN
Drug	Adamantamine fumarate [80789-67-9]; Down 200; 9.6uM; MCF7; HT_HG-U133A	SPN DVL3 DNAJC6 PHF2 MDN1 RAD23B	3.30e-04	194	108	6	3280_DN
Drug	Androsterone [53-41-8]; Down 200; 13.8uM; MCF7; HT_HG-U133A	DOCK1 DLG5 MAP4 RAD54L2 WNK1 PHKA2	3.30e-04	194	108	6	5696_DN
Drug	AC1L1FZH	PPHLN1 MUC5AC	3.30e-04	6	108	2	CID000003459
Drug	tetrahydroprotoberberine	SPN HOXD13	3.30e-04	6	108	2	CID000101707
Drug	coriphosphine	SPN HOXD13	3.30e-04	6	108	2	CID000021234
Drug	ethyl-p-((E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphthyl)-1-propenyl)benzoic acid	KRT5 KRT13	3.30e-04	6	108	2	ctd:C034814
Drug	dB to 2	VEZF1 APPL1	3.30e-04	6	108	2	CID000013908
Drug	ClOClO	KRT5 HOXD13	3.30e-04	6	108	2	CID000517862
Drug	Karakoline [39089-30-0]; Down 200; 10.6uM; MCF7; HT_HG-U133A	SPN MAP4 SRCAP PHKA2 CBFA2T2 MIR9-1HG	3.39e-04	195	108	6	6059_DN
Drug	Naloxone hydrochloride [357-08-4]; Down 200; 11uM; HL60; HG-U133A	MAP4 C11orf24 FRYL KMT2A APPL1 RAD23B	3.39e-04	195	108	6	2006_DN
Drug	S(+)-Terguride [37686-84-3]; Up 200; 11.8uM; HL60; HT_HG-U133A	ANK3 MAP1A CLIP2 MAP4 CBFA2T2 MCM3AP	3.39e-04	195	108	6	3082_UP
Drug	Phenazopyridine hydrochloride [136-40-3]; Down 200; 16uM; MCF7; HT_HG-U133A	KRT13 CLASP1 SPN MAP4 RAD54L2 PHF2	3.39e-04	195	108	6	6234_DN
Drug	Iressa; Down 200; 10uM; HL60; HG-U133A	C11orf24 WNK1 CBFA2T2 SEC24B ELF1 RAD23B	3.39e-04	195	108	6	541_DN
Drug	Bambuterol hydrochloride [81732-46-9]; Down 200; 10uM; HL60; HG-U133A	PEX14 C11orf24 WNK1 VPS35L KMT2A RAD23B	3.39e-04	195	108	6	1582_DN
Drug	Prednicarbate [73771-04-7]; Up 200; 8.2uM; MCF7; HT_HG-U133A	CLIP2 DVL3 SRF CCDC57 MAP3K1 EBF2	3.39e-04	195	108	6	3542_UP
Drug	Dicumarol [66-76-2]; Down 200; 11.8uM; MCF7; HT_HG-U133A	RALGDS MUC5B RAD54L2 SRCAP CBFA2T2 KMT2A	3.39e-04	195	108	6	3941_DN
Drug	ICI182,780; Up 200; 1uM; PC3; HT_HG-U133A	TPR RALGDS WNK1 ALMS1 KMT2A RAD23B	3.39e-04	195	108	6	6918_UP
Drug	Azathymine, 6 [932-53-6]; Down 200; 31.4uM; MCF7; HT_HG-U133A	SPN MAP4 MTMR1 WNK1 MCM3AP MIR9-1HG	3.39e-04	195	108	6	4106_DN
Drug	radicicol; Down 200; 0.1uM; MCF7; HT_HG-U133A_EA	EGLN2 C11orf24 ALMS1 KMT2A ZFYVE26 MUC1	3.39e-04	195	108	6	953_DN
Drug	Sulfadiazine [68-35-9]; Up 200; 16uM; HL60; HT_HG-U133A	DLG5 SPN MTMR1 SRCAP PHKA2 MUC1	3.48e-04	196	108	6	1852_UP
Drug	Benperidol [2062-84-2]; Down 200; 10.4uM; PC3; HT_HG-U133A	MAP1A MAP4 EBF2 KANSL3 HOXD13 MUC1	3.48e-04	196	108	6	4196_DN
Drug	Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A	CLIP2 SPN RAD54L2 WNK1 ALMS1 SMARCA4	3.48e-04	196	108	6	1323_UP
Drug	Thioproperazine dimesylate [2347-80-0]; Down 200; 6.2uM; MCF7; HT_HG-U133A	RALGDS SPN MAP4 C11orf24 PLEKHG3 CLPTM1	3.48e-04	196	108	6	2236_DN
Drug	Clofilium tosylate [92953-10-1]; Down 200; 7.8uM; MCF7; HT_HG-U133A	DLG5 KRT13 MAP4 WNK1 DNAJC6 MCM3AP	3.48e-04	196	108	6	3187_DN
Disease	cholangiocarcinoma (is_marker_for)	MUC16 MUC5B MUC1 MUC3A MUC4 MUC5AC MUC6	4.03e-09	64	109	7	DOID:4947 (is_marker_for)
Disease	mucinous adenocarcinoma (is_marker_for)	MUC4 MUC5AC MUC6	4.88e-07	5	109	3	DOID:3030 (is_marker_for)
Disease	common bile duct neoplasm (is_marker_for)	MUC1 MUC4 MUC5AC	2.71e-06	8	109	3	DOID:4608 (is_marker_for)
Disease	pancreatic ductal carcinoma (is_marker_for)	MUC5B MUC1 MUC3A MUC4 MUC5AC	3.16e-06	61	109	5	DOID:3587 (is_marker_for)
Disease	dry eye syndrome (is_marker_for)	MUC16 MUC1 MUC5AC	5.77e-06	10	109	3	DOID:10140 (is_marker_for)
Disease	gastric ulcer (implicated_via_orthology)	MUC5AC MUC6 HRH3	1.73e-05	14	109	3	DOID:10808 (implicated_via_orthology)
Disease	Neurodevelopmental Disorders	SRCAP PHF2 SETD5 ASXL3 KMT2A	2.52e-05	93	109	5	C1535926
Disease	otitis media (biomarker_via_orthology)	MUC1 MUC4 MUC5AC	3.21e-05	17	109	3	DOID:10754 (biomarker_via_orthology)
Disease	pancreatic cancer (is_marker_for)	MUC16 MUC1 MUC4 MUC5AC MUC6	3.75e-05	101	109	5	DOID:1793 (is_marker_for)
Disease	EPIDERMOLYSIS BULLOSA SIMPLEX, AUTOSOMAL RECESSIVE (disorder)	KRT5 DST	4.05e-05	3	109	2	C1832926
Disease	keratoconjunctivitis (is_marker_for)	MUC16 MUC5AC	4.05e-05	3	109	2	DOID:9368 (is_marker_for)
Disease	Robinow Syndrome	DVL1 DVL3	8.07e-05	4	109	2	C0265205
Disease	dry eye syndrome (is_implicated_in)	MUC1 MUC5AC	8.07e-05	4	109	2	DOID:10140 (is_implicated_in)
Disease	Robinow Syndrome, Autosomal Dominant	DVL1 DVL3	8.07e-05	4	109	2	C4551476
Disease	Sjogren's syndrome (is_marker_for)	MUC19 MUC16 MUC5AC	9.38e-05	24	109	3	DOID:12894 (is_marker_for)
Disease	Epidermolysis Bullosa Simplex	KRT5 DST	1.34e-04	5	109	2	C0079298
Disease	epidermolysis bullosa simplex (is_implicated_in)	KRT5 DST	2.81e-04	7	109	2	DOID:4644 (is_implicated_in)
Disease	biliary tract benign neoplasm (is_marker_for)	MUC4 MUC5AC	2.81e-04	7	109	2	DOID:0050625 (is_marker_for)
Disease	pseudohypoaldosteronism (is_implicated_in)	WNK1 NR3C2	3.73e-04	8	109	2	DOID:4479 (is_implicated_in)
Disease	Cornelia De Lange Syndrome	SETD5 KMT2A	3.73e-04	8	109	2	C0270972
Disease	2-aminooctanoate measurement	ALMS1 TMEM266	3.73e-04	8	109	2	EFO_0800349
Disease	Pseudohypoaldosteronism, Type I	WNK1 NR3C2	5.97e-04	10	109	2	C0268436
Disease	2-ketocaprylate measurement	ALMS1 TMEM266	5.97e-04	10	109	2	EFO_0800110
Disease	Pseudohypoaldosteronism	WNK1 NR3C2	5.97e-04	10	109	2	C0033805
Disease	otitis media (is_marker_for)	MUC5B MUC4	5.97e-04	10	109	2	DOID:10754 (is_marker_for)
Disease	Hyperpotassemia and Hypertension, Familial	WNK1 NR3C2	5.97e-04	10	109	2	C2713447
Disease	Pseudohypoaldosteronism, Type I, Autosomal Recessive	WNK1 NR3C2	5.97e-04	10	109	2	C1449843
Disease	Pseudohypoaldosteronism, Type II	WNK1 NR3C2	5.97e-04	10	109	2	C1449844
Disease	Pseudohypoaldosteronism, Type I, Autosomal Dominant	WNK1 NR3C2	5.97e-04	10	109	2	C1449842
Disease	allergic conjunctivitis (is_marker_for)	MUC1 MUC4	5.97e-04	10	109	2	DOID:11204 (is_marker_for)
Disease	allergic rhinitis (biomarker_via_orthology)	MUC1 MUC5AC	5.97e-04	10	109	2	DOID:4481 (biomarker_via_orthology)
Disease	pulmonary fibrosis	MUC5B MUC5AC	7.28e-04	11	109	2	EFO_0009448
Disease	N-acetyl-2-aminooctanoate measurement	ALMS1 TMEM266	8.71e-04	12	109	2	EFO_0800567
Disease	lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma	DVL1 MAP3K1 ATXN2	9.50e-04	52	109	3	EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575
Disease	cholangiocarcinoma (biomarker_via_orthology)	MUC1 MUC4	1.03e-03	13	109	2	DOID:4947 (biomarker_via_orthology)
Disease	Fetal Alcohol Spectrum Disorders	ANK3 SRF	1.03e-03	13	109	2	C2985290
Disease	eosinophil count	KLF12 PEX14 ZNF362 WNK1 KANSL3 MDN1 ATXN2 POC1B SMARCA4 UNK ELF1 NEURL1B MUC22 MUC5AC	1.17e-03	1488	109	14	EFO_0004842
Disease	apolipoprotein A 1 measurement	XIRP1 MAP1A CELF1 ATXN2 MUC17 CLPTM1 KMT2A MUC1 PHIP FOXK1	1.20e-03	848	109	10	EFO_0004614
Disease	alkaline phosphatase measurement	RALGDS KLF12 DLG5 MAP1A MAP4 SERTAD2 ATXN2 CLPTM1 ELF1 NR3C2 MUC22	1.35e-03	1015	109	11	EFO_0004533
Disease	choline measurement	CELF1 ATXN2 SMARCA4 MUC1	1.40e-03	130	109	4	EFO_0010116
Disease	total cholesterol measurement, very low density lipoprotein cholesterol measurement	MAP1A ATXN2 CLPTM1 SMARCA4 MUC1	1.49e-03	224	109	5	EFO_0004574, EFO_0008317
Disease	endoplasmic reticulum resident protein 29 measurement	MUC21 MUC22	1.57e-03	16	109	2	EFO_0020346
Disease	Rolandic epilepsy	CADM2 NR3C2	1.57e-03	16	109	2	Orphanet_1945
Disease	cystic fibrosis (is_marker_for)	MUC5B MUC1 MUC5AC	1.58e-03	62	109	3	DOID:1485 (is_marker_for)
Disease	C-reactive protein measurement	ANK3 MAP1A PEX14 DNAJC6 MAP3K1 CELF1 SETD5 CLPTM1 POC1B SMARCA4 QSER1 NEURL1B	1.68e-03	1206	109	12	EFO_0004458
Disease	prostate carcinoma	RBM15 PEX14 MAP3K1 EZHIP EBF2 CCDC88C QSER1 MUC22 PHIP RAD23B	1.73e-03	891	109	10	EFO_0001663
Disease	Fetal Alcohol Syndrome	ANK3 SRF	1.77e-03	17	109	2	C0015923
Disease	waist-hip ratio	ANK3 C11orf24 WNK1 CADM2 EBF2 CELF1 ATXN2 POC1B NEURL1B MUC1 PHIP MIR9-1HG	1.92e-03	1226	109	12	EFO_0004343
Disease	neuroimaging measurement	SECISBP2L ANK3 FRYL MAP3K1 CCDC88C STAC2 CELF1 ATXN2 CBFA2T2 QSER1 RAD23B	2.02e-03	1069	109	11	EFO_0004346
Disease	cardiomyopathy (is_implicated_in)	SRF TAB2	2.22e-03	19	109	2	DOID:0050700 (is_implicated_in)
Disease	stroke, coronary artery disease	SMARCA4 MUC1	2.71e-03	21	109	2	EFO_0000712, EFO_0001645
Disease	prostate cancer (is_marker_for)	SETD5 SMARCA4 KMT2A MUC1	2.72e-03	156	109	4	DOID:10283 (is_marker_for)
Disease	nicotine dependence	KLF12 EGLN2 DVL1	3.05e-03	78	109	3	EFO_0003768

Protein segments in the cluster

Peptide	Gene	Start	Entry
VTSSGTAPSTTVSTA	CEP170	1326	Q5SW79
VSPSSTTSSRCSSRD	AKAP2	151	Q9Y2D5
SSIESSDPSLSSSAT	ELF1	306	P32519
TSFSTTPTDRTATSL	ADGRG4	976	Q8IZF6
TSSSPLSVLTSSGSS	CELF1	286	Q92879
LSVLTSSGSSPSSSS	CELF1	291	Q92879
SRPASDSVTGTSESS	ARHGEF38	671	Q9NXL2
PAVTSTSSASSSLGE	ALMS1	851	Q8TCU4
TVGSSSTSSILPFSS	EBF2	516	Q9HAK2
TASPSTSSIDSATDT	ACAP3	381	Q96P50
SSVSSVASSVGGRPS	CLIP2	321	Q9UDT6
GPVSSSSTATSVTAS	RAD54L2	1351	Q9Y4B4
SRVPSSSSISSSSGS	CDSN	396	Q15517
STSSSITSSIPDTER	DVL3	386	Q92997
RATSSTTDSSRAPSS	MIR9-1HG	46	Q13536
SKPESRASTSTSVSG	ASXL3	1031	Q9C0F0
TTASTGSTATPTSTL	MUC5B	1916	Q9HC84
TTPGHTTATSRTTAT	MUC5B	2271	Q9HC84
TTATTTESTGSTATP	MUC5B	2441	Q9HC84
GTTTPGHTRATSRTT	MUC5B	2826	Q9HC84
TTTATTGSTAIPSST	MUC5B	3001	Q9HC84
SSKATSSSSPRTATT	MUC5B	3036	Q9HC84
ATVTVPTGSTATASS	MUC5B	3171	Q9HC84
PTGSTATASSTRATA	MUC5B	3176	Q9HC84
ATTTRATGSVATPSS	MUC5B	3841	Q9HC84
ATTITATGSTTNPSS	MUC5B	3951	Q9HC84
TPGHTTATSRTTATA	MUC5B	4086	Q9HC84
TATTTASTGSTATPS	MUC5B	4256	Q9HC84
TTAATTTAATGPTAT	MUC5B	4396	Q9HC84
TTATTTASTGSTATP	MUC5B	4426	Q9HC84
ATGSTATLSSTPGTT	MUC5B	4831	Q9HC84
ASTVPSSSTVGTTRT	MUC5B	4891	Q9HC84
TRAVSSSSERGSSPS	MTMR1	641	Q13613
TTTATTTTTSSGGHP	RAD23B	261	P54727
LAVPGSSDSRSSSSS	RBM15	861	Q96T37
TSPTANTTGTATTSS	QSER1	1271	Q2KHR3
LGGTSTSALTTTSPS	MUC16	396	Q8WXI7
TGLPSATTTVSTSAT	MUC16	976	Q8WXI7
TSTSERTLSPSDTTA	MUC16	3656	Q8WXI7
TSSTTQTSIISSPGS	MUC16	4026	Q8WXI7
TSESTFTLDTSTTPS	MUC16	7336	Q8WXI7
ILGTSTEPGTSSSSS	MUC16	7731	Q8WXI7
TEPGTSSSSSLSTTS	MUC16	7736	Q8WXI7
TSVSTSTPGFFETSR	MUC16	8096	Q8WXI7
TSSLTSGLRETSSSE	MUC16	8411	Q8WXI7
TSSSERISSATEGST	MUC16	8421	Q8WXI7
SSGTDSTTTFPTLTE	MUC16	11466	Q8WXI7
SSVSTTSTPGTSTVD	MUC16	12351	Q8WXI7
TSTPGTSTVDLRTSG	MUC16	12356	Q8WXI7
TAGTESSTPVTSAVS	MUC4	156	Q99102
QTSEPASSGSRTTSA	MUC4	786	Q99102
ASSGSRTTSAGTATP	MUC4	791	Q99102
RTTSAGTATPSSSGA	MUC4	796	Q99102
LPVTSFSSASTGDST	MUC4	1041	Q99102
PVTDASSASTGDTTS	MUC4	1826	Q99102
VTSTSSASTGDTTPL	MUC4	2451	Q99102
ATSLPVTDTSSASTG	MUC4	2686	Q99102
GDTTSLPVTDTSSSS	MUC4	2716	Q99102
LPVTDTSSSSTGDTT	MUC4	2721	Q99102
ALPVTSTSSASTGDT	MUC4	3136	Q99102
ATSLPVTDTSSASTG	MUC4	3246	Q99102
GDTTSLPVTDTSSSS	MUC4	3276	Q99102
LPVTDTSSSSTGDTT	MUC4	3281	Q99102
DTSTLPVTGASSAST	MUC4	3501	Q99102
TSSASTGDTTRLPVT	MUC4	3606	Q99102
PVTDTSSASTGDTTR	MUC4	3666	Q99102
ATSLPVTSRSSASTG	MUC4	3966	Q99102
TRATASTASPATTST	MUC6	1306	Q6W4X9
TGTRTPVAHTTSATS	MUC6	1776	Q6W4X9
VSPGGRTSRSTSVSS	KCND1	506	Q9NSA2
TRSTVVGSPTSSVST	MDN1	2351	Q9NU22
VTSDISPSSTSTAGS	H1-8	6	Q8IZA3
SSTLRSVSTGSSRPS	NR3C2	586	P08235
SEGSSSEATTPVISS	MAP1A	2256	P78559
SVVSTGTSFSSSSPG	MAVS	246	Q7Z434
TTAAAVASTGPSSRS	MAP4	811	P27816
ETSSRTSGAPVTTAA	SPN	141	P16150
GISTVTNSESSTPSS	MUC21	281	Q5SSG8
SGTTIASTRTFTTGS	MUC22	101	E2RYF6
ETTTASTAGSETTTP	MUC22	286	E2RYF6
PASTAGSETTTTTST	MUC22	1086	E2RYF6
TGSETSTPSSAGSET	MUC22	1471	E2RYF6
SSTTSAHGVRTTTGS	MUC22	1606	E2RYF6
TTTGSTREPTSSTFQ	MUC22	1616	E2RYF6
SSRGASPNRSTSVSS	DST	7411	Q03001
SSSATAPSSVVAATS	ATXN2	221	Q99700
STTSSSAFSPVAGTT	KIAA2026	1326	Q5HYC2
SAFSPVAGTTTTSSL	KIAA2026	1331	Q5HYC2
SFSTASAITPSVSRT	KRT5	16	P13647
PTARTSSSGSLGSES	APPL1	421	Q9UKG1
STSTTPGTGLRSRST	EZHIP	336	Q86X51
STFVATSGPSSSSVL	MCM3AP	91	O60318
SSAGSVSPRSTSVTT	KRT13	421	P13646
VSPRSTSVTTTSSAS	KRT13	426	P13646
GTSARATTTPASKST	MUC1	976	P15941
GSRTCSTSATTTAPS	CCDC88C	1516	Q9P219
DKTSATTSRSSTPAS	CBFA2T2	581	O43439
SITASPGASATSSES	MUC19	1791	Q7Z5P9
ESSTSRPLGETTGTT	MUC19	2356	Q7Z5P9
SSTTRSSDGTTGTTR	MUC19	2556	Q7Z5P9
TTGSSTVGLETTRPS	MUC19	2846	Q7Z5P9
TTESSAVRSGTTGPT	MUC19	3216	Q7Z5P9
TSTSVEESRTTRPSA	MUC19	3606	Q7Z5P9
TETTGSSARSGTSTP	MUC19	4411	Q7Z5P9
SSARSGTSTPSVGET	MUC19	4416	Q7Z5P9
TTRTSVEESTTTGPS	MUC19	5891	Q7Z5P9
SSTSQSSRPGTSVTP	MUC19	6831	Q7Z5P9
TTVAPGSFSTAATTS	MUC19	6961	Q7Z5P9
SGITRAGPTSETTTS	MUC19	7261	Q7Z5P9
STATISPGASRTTGA	MUC19	7411	Q7Z5P9
TTVAPGSSSTEATTS	MUC19	7846	Q7Z5P9
TTHTESISSPRGTTS	MUC3A	921	Q02505
SISSPRGTTSTLHTT	MUC3A	926	Q02505
TPGFTSSITTTETTS	MUC3A	2236	Q02505
TTSLRTLTPSSVGTS	MUC3A	2486	Q02505
SVGTSTSLTTTTDFP	MUC3A	2496	Q02505
PTTVTFGSTDSSTST	MUC3A	2596	Q02505
SDLTTSSSSSGPRVS	DCAF10	351	Q5QP82
SVASSTGSPASIRTT	FAM83D	486	Q9H4H8
TSSSSTSAGSVRCSP	FRYL	876	O94915
SSESEATLVGSSPST	DLG5	1031	Q8TDM6
TARTTSAPTTRTTSA	MUC5AC	2281	P98088
TSATTTSRISGPETT	MUC5AC	2381	P98088
TRTTSAPKSSTTSAA	MUC5AC	2466	P98088
TTSAATTSTTSGPET	MUC5AC	2476	P98088
TTSATTTSTTSGPGT	MUC5AC	2556	P98088
TSATTTSRISGPETT	MUC5AC	2621	P98088
STTSASTTSITSGPG	MUC5AC	3051	P98088
TTSTIFAPRTSTTSA	MUC5AC	3161	P98088
FAPRTSTTSASTTST	MUC5AC	3166	P98088
SAPTSSTISARTTSI	MUC5AC	3416	P98088
TSAATTSTTSAPTTR	MUC5AC	4266	P98088
TTSASTASTTSGPGT	MUC5AC	4361	P98088
TSAPTTRTTSASTAS	MUC5AC	4386	P98088
TRTTSASTASTTSGP	MUC5AC	4391	P98088
SFDSTTTTETSGRTL	POC1B	366	Q8TC44
SSAATPSSRTSLVAS	OR7C1	261	O76099
PQTEVGSSSSASTST	HECTD1	1436	Q9ULT8
TSVESLGSPSSLSSS	C5orf60	181	A6NFR6
SVASVSSLSSDSTPS	DOCK1	1646	Q14185
TQTGASATSTRGTSP	FAM117B	111	Q6P1L5
SATSTRGTSPTRSAA	FAM117B	116	Q6P1L5
ERTGSSSSSSSSAVV	HOXD13	81	P35453
TQSTPRRSATSTSAS	DNAJC6	556	O75061
TTSPTTSATTSSIRD	CADM2	341	Q8N3J6
TTTPATATTASASAS	FOXK1	681	P85037
TATTASASASSTGEP	FOXK1	686	P85037
SQPSVRTSTETTGGS	CCDC57	616	Q2TAC2
SNSTFSSRTSPVTTA	ANK3	1616	Q12955
SPETSGISSASSSTS	RALGDS	746	Q12967
ASPTSSSGSSSRGTE	HRH3	301	Q9Y5N1
GSEDLSSVSSSPTSS	KANSL3	526	Q9P2N6
SSSSSSRLASSPTVI	KLF12	116	Q9Y4X4
SSRSSSPSVDTSTDS	KMT2A	476	Q03164
PCSSAVTRTSSSSLT	DVL1	381	O14640
VTRTSSSSLTSSVPG	DVL1	386	O14640
SGTPRATATSTTASP	EGLN2	61	Q96KS0
TVLSGSSGSSSTRTP	SEC24B	316	O95487
SRDTSPSSGSAVSSS	PPHLN1	201	Q8NEY8
SARSSTPSSPTGTSS	PHKA2	1036	P46019
TPTESRTTSESTSDS	MUC17	111	Q685J3
RTTSESTSDSTTLFP	MUC17	116	Q685J3
SSSPTTAEDTSIATS	MUC17	431	Q685J3
SEASSSSTTPEGTSI	MUC17	546	Q685J3
STTPADSNTFVTTSS	MUC17	591	Q685J3
TTSTEATSSPTTAEG	MUC17	956	Q685J3
SSETSTLSTTPADTS	MUC17	1056	Q685J3
TEASSSPTTAEGTSI	MUC17	1136	Q685J3
TTSAETSSSPTTAEG	MUC17	1251	Q685J3
VDTSTPGTTSAEATS	MUC17	1421	Q685J3
TTSTEATSSPTTAEG	MUC17	1781	Q685J3
DTSTPATTSTEGSSS	MUC17	2011	Q685J3
ATTSTEGSSSPTTAG	MUC17	2016	Q685J3
STEASSSPTTAEGTS	MUC17	2431	Q685J3
RTLVTTSTGTSSSPT	MUC17	2661	Q685J3
TSTGTSSSPTTAEGS	MUC17	2666	Q685J3
TSAEASSSPTTAEGT	MUC17	2961	Q685J3
ATSSTTAEGTSIPTS	MUC17	3201	Q685J3
SETSTLSTTPADTST	MUC17	3296	Q685J3
TTSTEASSSPTIAEG	MUC17	3431	Q685J3
SPGATGTLSTATSTS	MUC3B	16	Q9H195
SSSTTAITSPFTTAE	MUC3B	366	Q9H195
LASISVGPSSSTTTT	MAP3K1	931	Q13233
SGATSTTTTTSALAP	SFSWAP	431	Q12872
VTRSAAPSTLDSSST	SRPRB	206	Q9Y5M8
SISAGTTSTSTTPAS	PHF2	971	O75151
LRSSGPRTSSTSSSV	TAB2	341	Q9NYJ8
GSSESLASPSTSRAT	NHSL2	671	Q5HYW2
PVSLTSTTSSSGSSC	PLEKHG3	16	A1L390
GALDLTTSSSPTTTT	RASGRF2	756	O14827
DSDAGSSTPTTSTRS	SMARCA4	1416	P51532
PTSDSVSQSSTGTLS	SETD5	1356	Q9C0A6
PSLVATGSTTSATSA	SECISBP2L	921	Q93073
ERESTSGSSVSSSVS	TSC22D1	461	Q15714
SSARTSTSVRASTPT	SELENOV	11	P59797
PAAATTTSTTTATAT	SRCAP	1141	Q6ZRS2
AEVAAPSTSSSATSS	SRCAP	2696	Q6ZRS2
PASSTSSSSIRSVSS	SWT1	36	Q5T5J6
SSDISPVSNESTSSS	PEX14	261	O75381
PSRDSSTDLTQTSSS	SRF	371	P11831
APTTTTATREEASTS	CLPTM1	626	O96005
RSPTGSTTSRASTVS	CLASP1	571	Q7Z460
STSTGRTPSTTATGH	C11orf24	171	Q96F05
STSSSSSSSVVDPLS	VPS35L	56	Q7Z3J2
LSTVTTSSSGTNPSS	VEZF1	136	Q14119
TLTTPFSITSSVSSG	VEZF1	396	Q14119
RSSSVSSSAASSPER	PHIP	1446	Q8WWQ0
SESSTSAFSTPTRSI	PHIP	1471	Q8WWQ0
PTSTSTEAATAATDS	SERTAD2	181	Q14140
TSTAVFGTVSATPSS	TPR	1811	P12270
SFSSTSESPTRSLSE	STAC2	221	Q6ZMT1
SSSASESSLVTAPSS	NEURL1B	466	A8MQ27
LTGTSSTASLTRTPS	nan	381	Q9UF83
SQVPGLSSTTSTTST	USF3	956	Q68DE3
VSRDTSSSPTTGSTV	RWDD2B	166	P57060
TGLGLSTRTPSVSTS	ZNF362	116	Q5T0B9
STRTPSVSTSESSAG	ZNF362	121	Q5T0B9
TGIPTASTTSASVST	WNK1	611	Q9H4A3
GATLTSVSTTTSFPS	WNK1	1486	Q9H4A3
ESSTSESSVLSSSSP	WNK1	1886	Q9H4A3
GSPLTSSISSSITSS	UNK	466	Q9C0B0
SASSTPDSTRSARSG	TOPBP1	1101	Q92547
PSLESTSSELSTSTS	ZFYVE26	786	Q68DK2
ISVTVSSSARPSGSG	XIRP1	1586	Q702N8
GTSATSESASRSSVT	TMEM266	381	Q2M3C6
PARTTSSGVSEKSTT	MUC12	296	Q9UKN1
SPASTTSSGVSEEST	MUC12	981	Q9UKN1
TSSGVSEESTTSRSR	MUC12	986	Q9UKN1
SEESTTSRSRPGSTH	MUC12	991	Q9UKN1
STDTTLLPASTTTSG	MUC12	1031	Q9UKN1
SSGSTDTALSPGSTT	MUC12	1056	Q9UKN1
ESTTSRSQPGSTHST	MUC12	1271	Q9UKN1
DATLSPATTTSSGVS	MUC12	1451	Q9UKN1
PATTTSSGVSEESST	MUC12	1456	Q9UKN1
SPASTTSSGVSEEST	MUC12	1706	Q9UKN1
STDTTLSPGSTTASS	MUC12	1756	Q9UKN1
TTLSPASTTSSGVSE	MUC12	2061	Q9UKN1
STTSGRGESTTSRIS	MUC12	2291	Q9UKN1
TTSRSQPGSTHSTVS	MUC12	2356	Q9UKN1
ESTTFPSSSGSTGTT	MUC12	2466	Q9UKN1
STGTTLSPARSTTSG	MUC12	2476	Q9UKN1
ASTTTSGPSQESTTS	MUC12	2596	Q9UKN1
TTSGRGESTTSRISP	MUC12	2766	Q9UKN1
GSTETTVFPRSTTTS	MUC12	2866	Q9UKN1
STTFPSSSGSTGTTL	MUC12	2941	Q9UKN1
SSSGSTGTTLSPARS	MUC12	2946	Q9UKN1
TGTTLSPARSTTSGL	MUC12	2951	Q9UKN1
GSTEATLSPGSTTAS	MUC12	3061	Q9UKN1
TTSPISSGSTETTAL	MUC12	3221	Q9UKN1
SSGSTETTALPGSTT	MUC12	3226	Q9UKN1
SPASTTSSGVSEEST	MUC12	3621	Q9UKN1
STDTTLLPASTTTSG	MUC12	3671	Q9UKN1
SSGSTDTALSPGSTT	MUC12	3696	Q9UKN1
ESTTSRSQPGSTHST	MUC12	3911	Q9UKN1
SSPGSTETTVFPRST	MUC12	3946	Q9UKN1
DATLSPATTTSSGVS	MUC12	4091	Q9UKN1
PATTTSSGVSEESST	MUC12	4096	Q9UKN1
SPASTTSSGVSEEST	MUC12	4346	Q9UKN1
STDTTLSPGSTTASS	MUC12	4396	Q9UKN1
ATATTPSPARSTTSG	MUC12	4726	Q9UKN1
STETTLSPGSITTSS	MUC12	4946	Q9UKN1